Exclusions for E4_PCOS_CONSORTIUM

E4_PCOS_CONSORTIUM_EXCLUSIONS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E2839\|E24\|E23[0-4]\|E25\|F50\|F11\|D25\|D352\|E22\|E221\|C56\|D27\|Q96\|N643\|C74 Hospital discharge: ICD-9 — 2563\|25631\|2568\|2550\|2580\|2434A\|2532[AB]2552\|3071A\|3072A\|3075[AB]\|304\|2180\|253X\|2531X\|2531A\|2395\|220\|7586\|2531A\|2270\|1940 Hospital discharge: ICD-8 — 2561\|255\|258\|2561\|255\|3065\|304\|21899\|2262\|253\|253\|183\|22099\|7595\|253\|2260 Cause of death: ICD-10 — E2839\|E24\|E23[0-4]\|E25\|F50\|F11\|D25\|D352\|E22\|E221\|C56\|D27\|Q96\|N643\|C74 Cause of death: ICD-9 — 2563\|25631\|2568\|2550\|2580\|2434A\|2532[AB]2552\|3071A\|3072A\|3075[AB]\|304\|2180\|253X\|2531X\|2531A\|2395\|220\|7586\|2531A\|2270\|1940 Cause of death: ICD-8 — 2561\|255\|258\|2561\|255\|3065\|304\|21899\|2262\|253\|253\|183\|22099\|7595\|253\|2260 2 out of 7 registries used, show all original rules.	61519
4. Check minimum number of events None	61519
5. Include endpoints None	61519
6. Filter based on genotype QC (FinnGen only)	61519

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	E4_PCOS_CONSORTIUM_EXCLUSIONS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E2839\|E24\|E23[0-4]\|E25\|F50\|F11\|D25\|D352\|E22\|E221\|C56\|D27\|Q96\|N643\|C74
HD_ICD_9	2563\|25631\|2568\|2550\|2580\|2434A\|2532[AB]2552\|3071A\|3072A\|3075[AB]\|304\|2180\|253X\|2531X\|2531A\|2395\|220\|7586\|2531A\|2270\|1940
HD_ICD_8	2561\|255\|258\|2561\|255\|3065\|304\|21899\|2262\|253\|253\|183\|22099\|7595\|253\|2260
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E2839\|E24\|E23[0-4]\|E25\|F50\|F11\|D25\|D352\|E22\|E221\|C56\|D27\|Q96\|N643\|C74
COD_ICD_9	2563\|25631\|2568\|2550\|2580\|2434A\|2532[AB]2552\|3071A\|3072A\|3075[AB]\|304\|2180\|253X\|2531X\|2531A\|2395\|220\|7586\|2531A\|2270\|1940
COD_ICD_8	2561\|255\|258\|2561\|255\|3065\|304\|21899\|2262\|253\|253\|183\|22099\|7595\|253\|2260
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Exclusions for E4_PCOS_CONSORTIUM based on the number of shared cases.

Similar with more cases:

Any event in hilmo or specialist outpatient

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	61519	57318	4201
Unadjusted period prevalence (%)	18.33	19.54	1.85
Median age at first event (years)	45.33	45.47	43.41

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12322: Matched controls
109886

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

151.7

323.0

599

F50.0

ICD-10 Finland

Anorexia nervosa

421.2

323.0

1004

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.0

323.0

1265

2459

D25.2

ICD-10 Finland

Subserosal leiomyoma of uterus

110.6

323.0

557

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

125.8

323.0

2079

177

E22.1

ICD-10 Finland

Hyperprolactinaemia

186.9

323.0

730

F50.2

ICD-10 Finland

Bulimia nervosa

137.0

323.0

791

F50.8

ICD-10 Finland

Other eating disorders

106.3

323.0

448

F50.3

ICD-10 Finland

Atypical bulimia nervosa

109.1

323.0

516

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

432.8

323.0

378

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

58.5

323.0

816

133

D25.1

ICD-10 Finland

Intramural leiomyoma of uterus

84.4

323.0

1150

134

N05AH04

ATC

quetiapine; oral

3.2

323.0

3446

11846

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

4384.6

323.0

930

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.8

323.0

2603

9739

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

1136.0

323.0

371

N06AB03

ATC

fluoxetine; oral

3.8

323.0

2197

5914

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

97.3

323.0

891

101

Kela drug reimbursment

Anterior pituitary hypofunction

181.3

323.0

781

D25.0

ICD-10 Finland

Submucous leiomyoma of uterus

228.4

323.0

769

B18.2

ICD-10 Finland

Chronic viral hepatitis C

20.2

323.0

714

334

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

516.5

323.0

448

F50.1

ICD-10 Finland

Atypical anorexia nervosa

308.8

323.0

742

F50.9

ICD-10 Finland

Eating disorder, unspecified

126.5

323.0

1409

112

E23.00

ICD-10 Finland

Panhypopituitarism

+∞

323.0

414

H02AB09

ATC

hydrocortisone; systemic

9.6

323.0

826

814

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

7.2

323.0

1248

1687

N05AH03

ATC

olanzapine; systemic

4.1

318.7

1390

3299

N05BA04

ATC

oxazepam; oral

2.4

313.8

3384

14920

N06AX16

ATC

venlafaxine; oral

2.8

299.4

2337

8562

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.2

297.9

1011

1851

N05BA01

ATC

diazepam; systemic, rectal

3.3

296.9

1755

5330

P19

ICPC

Drug abuse

14.3

295.0

531

346

N04BC06

ATC

cabergoline; oral (dopamine agonists)

53.2

292.2

365

N06AX11

ATC

mirtazapine; oral

2.2

291.0

3876

18802

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

392.4

289.0

302

LCA06

NOMESCO Finland

Biopsy of endometrium

3.7

278.9

1383

3651

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

29.2

276.1

391

123

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.5

273.0

1428

3934

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.1

264.9

4322

22695

H01AC01

ATC

somatropin; parenteral

43.3

259.2

336

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.3

255.6

1467

4328

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

397.4

251.7

263

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.6

249.5

2162

8327

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

15.5

245.8

427

254

Z72.2

ICD-10 Finland

Drug use

20.0

236.3

374

172

D27.91

ICD-10 Finland

Benign epithelial tumor of the ovary (ovary)

+∞

230.0

230

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

31.6

229.1

318

N05AA02

ATC

levomepromazine; systemic

5.3

229.1

761

1349

D27.92

ICD-10 Finland

Benign granulosa cell tumor in ovary (ovary)

707.8

227.8

234

N06AB04

ATC

citalopram; systemic

2.3

224.1

2652

11921

N05AX08

ATC

risperidone; systemic

3.3

222.1

1236

3542

P86

ICPC

Anorexia nervosa/bulimia

26.9

219.9

318

108

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

29.7

219.3

309

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

+∞

218.0

218

21899

ICD-8 Finland

Uterine fibroma

+∞

217.0

217

N03AE01

ATC

clonazepam; systemic

4.4

216.4

854

1817

N06AB06

ATC

sertraline; oral

2.5

213.9

1897

7340

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

210.0

1760

6590

LBE20

NOMESCO Finland

Laparoscopic bilateral salpingectomy

7.8

208.9

515

611

LCB14

NOMESCO Finland

Laparoscopic myolysis

80.9

204.4

240

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.4

202.4

2086

8714

N05AX12

ATC

aripiprazole; systemic

3.6

201.2

1000

2614

N03AX16

ATC

pregabalin; oral

2.3

196.1

2225

9725

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

210.6

193.9

209

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.8

193.4

909

2265

N05CF01

ATC

zopiclone; oral

2.0

191.7

2938

14633

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

7.5

190.6

480

588

N06AB10

ATC

escitalopram; oral

2.0

190.5

3197

16499

H03AA01

ATC

levothyroxine sodium; systemic

2.2

187.5

2432

11272

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.1

186.9

644

1185

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

37.1

183.3

245

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

34.0

178.3

243

N03AX09

ATC

lamotrigine; oral

3.1

173.8

1046

3152

E23.05

ICD-10 Finland

Lack of TSH

239.8

172.9

185

B02AA02

ATC

tranexamic acid; systemic

2.4

171.2

1645

6579

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

29.9

168.7

237

C07AA05

ATC

propranolol; systemic

2.0

168.5

2572

12688

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

2.5

167.4

1454

5504

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.9

167.3

1165

3867

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

5.7

167.2

519

844

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

45.1

166.7

214

N05CD07

ATC

temazepam; oral

3.1

165.6

1003

3030

LCB11

NOMESCO Finland

Laparoscopic myomectomy

510.8

164.0

170

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

28.6

161.9

230

G03XB02

ATC

ulipristal; oral (progesterone receptor modulators)

260.6

161.5

172

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.2

160.4

921

2677

F11.21

ICD-10 Finland

Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment

495.5

159.1

165

N05BA12

ATC

alprazolam; oral

2.8

158.2

1173

4044

D27.99

ICD-10 Finland

Benign tumor of the ovary (ovary), unspecified histology

370.9

157.5

165

N05AF03

ATC

chlorprothixene; systemic

5.2

157.0

528

943

N91.1

ICD-10 Finland

Secondary amenorrhoea

4.1

155.4

667

1527

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.5

154.9

1406

5434

N03AG01

ATC

valproic acid; systemic, rectal

3.0

153.7

976

3042

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.0

153.3

968

3006

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.6

151.3

1256

4620

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.2

151.2

899

2676

F11.30

ICD-10 Finland

Withdrawal symptoms caused by opiates uncomplicated

181.8

148.0

161

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.5

147.3

743

1952

LCD00

NOMESCO Finland

Hysterectomy

17.4

146.8

243

127

N06AX12

ATC

bupropion; oral

2.6

146.7

1241

4611

N06AX21

ATC

duloxetine; oral

2.5

146.6

1314

5039

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

14.6

146.4

259

161

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

88.3

143.0

166

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.8

142.2

1011

3386

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.9

142.1

425

659

N02AX02

ATC

tramadol; systemic, rectal

1.7

141.8

3718

21908

102

Kela drug reimbursment

Diabetes insipidus

334.1

141.6

149

E23.2

ICD-10 Finland

Diabetes insipidus

334.1

141.6

149

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

29.5

141.4

199

LCB10

NOMESCO Finland

Myomectomy

331.8

140.7

148

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

21.3

139.8

216

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

135.4

2318

11818

AA1AD

NOMESCO Finland

CT of head and brain

2.1

134.9

1854

8674

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

60.9

132.9

162

N02BE01

ATC

paracetamol; systemic, rectal

1.7

129.7

9345

71622

P18

ICPC

Medication abuse

13.7

129.2

235

156

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.7

127.3

607

1520

E23.03

ICD-10 Finland

Lack of ACTH

+∞

126.8

127

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.1

126.2

781

2382

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.3

125.5

699

1978

N05BE01

ATC

buspirone; oral

4.6

122.6

459

918

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

121.9

4511

28965

D25

ICD-10 Finland

Leiomyoma of uterus

15.9

121.1

207

118

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

29.5

120.9

170

A02BC02

ATC

pantoprazole; systemic

1.6

120.8

5943

40958

N06AB05

ATC

paroxetine; oral

2.8

119.3

850

2840

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

4.1

119.0

506

1145

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

118.9

3454

20735

AA4CM

NOMESCO Finland

Extensive MRI examination of sella turcica with 3 Tesla magnet

109.0

117.3

133

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.3

116.8

647

1822

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

2.9

116.7

792

2566

N03AX12

ATC

gabapentin; oral

2.2

116.4

1385

6060

WX402

NOMESCO Finland

General anaesthesia

1.9

116.0

1915

9570

N05BA06

ATC

lorazepam; systemic, sublingual

3.6

115.8

574

1482

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

115.7

2344

12585

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

29.9

115.6

162

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

7.3

114.0

291

363

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

+∞

113.8

114

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.0

113.8

1715

8273

N05CF02

ATC

zolpidem; oral

1.9

113.0

1798

8856

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.3

113.0

454

974

IBZ05

NOMESCO Finland

Evaluation of patient with eating disorder

520.6

112.0

116

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

6.9

111.7

297

393

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

2.2

111.3

1221

5139

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

111.0

1933

9831

186

Kela drug reimbursment

Growth retardation associated with renal failure (growth hormone)

66.7

110.7

133

N05AH02

ATC

clozapine; systemic

4.4

109.2

428

896

N07BB01

ATC

disulfiram; oral

3.2

108.9

626

1809

F61.0

ICD-10 Finland

Mixed personality disorders

4.6

108.8

408

817

E22.0

ICD-10 Finland

Acromegaly and pituitary gigantism

+∞

108.8

109

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

56.2

106.3

131

N64.3

ICD-10 Finland

Galactorrhoea not associated with childbirth

11.6

106.2

208

163

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.6

104.7

815

2866

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.0

104.7

358

650

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

26.7

102.7

148

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

28.4

102.3

145

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.4

102.1

539

1461

2395A

ICD-9 Finland

Neoplasm of unspecified nature, Other genito-urinary organs

+∞

100.8

101

LAF01

NOMESCO Finland

Laparoscopic unilateral salpingo-oophorectomy

5.3

99.7

324

555

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

11.3

99.0

196

157

G02CB01

ATC

bromocriptine; systemic

5.2

96.9

319

555

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.9

96.4

1565

7723

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

95.2

3189

19648

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

4.9

94.5

331

617

N05AB03

ATC

perphenazine; systemic, rectal

3.5

93.9

477

1254

E23.06

ICD-10 Finland

Empty sella

+∞

93.8

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

5.8

93.2

283

447

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

46.2

92.6

118

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.2

92.6

532

1535

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

92.5

2654

15676

D27.98

ICD-10 Finland

Benign tumor of the ovary (ovary), other specified histology

843.6

91.9

R53

ICD-10 Finland

Malaise and fatigue

1.7

90.2

2342

13435

SPAT1272

SPAT

Drug screening

10.0

89.8

189

171

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

5.9

89.1

265

408

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

4.3

88.6

355

759

F11.9

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, unspecified mental and behavioural disorder

807.4

87.9

E22.80

ICD-10 Finland

Central precocious puberty

407.0

87.3

3041A

ICD-9 Finland

Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence

+∞

86.8

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.5

86.2

736

2719

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.8

85.9

1719

9093

N05AN01

ATC

lithium; oral

3.6

85.2

416

1059

E23.02

ICD-10 Finland

Neurosecretory dysfunction of the growth hormone

+∞

84.8

E66.8

ICD-10 Finland

Other obesity

2.5

83.9

702

2562

E23.09

ICD-10 Finland

Pituitary insufficiency NOS

771.2

83.9

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.5

83.9

320

652

E22.2

ICD-10 Finland

Syndrome of inappropriate secretion of antidiuretic hormone

+∞

83.8

301

Kela drug reimbursment

Growth hormone

24.6

83.6

123

N05AD01

ATC

haloperidol; systemic

3.8

83.6

381

916

N06AA12

ATC

doxepin; systemic

3.3

83.5

451

1243

F60.2

ICD-10 Finland

Dissocial personality disorder

15.0

83.4

145

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.2

83.3

467

1323

P29

ICPC

Psychological sympt/compl other

2.1

82.8

1059

4743

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.0

82.5

354

807

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

81.8

950

4079

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

13.8

81.6

147

LCB25

NOMESCO Finland

Hysteroscopic excision of lesion

3.5

80.5

410

1080

P01AB01

ATC

metronidazole; oral, rectal

1.5

80.0

3882

25865

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.1

79.2

334

749

O34.1

ICD-10 Finland

Maternal care for tumour of corpus uteri

11.2

79.1

157

127

N06AX26

ATC

vortioxetine; oral

2.2

79.0

898

3816

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

78.6

1390

7037

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

77.2

1105

5174

LCD97

NOMESCO Finland

Other laparoscopic hysterectomy

111.6

77.1

AA4DG

NOMESCO Finland

Very extensive MRI examination of sella turcica with high intensity magnet

80.9

77.0

IFC01

NOMESCO Finland

Withdrawal and replacement therapy for opioid addiction

+∞

76.8

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

30.1

76.8

107

SPAT1240

SPAT

Therapeutic discussion

1.7

76.7

1847

10312

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.4

76.7

406

1102

LAF00

NOMESCO Finland

Unilateral salpingo-oophorectomy

11.2

75.7

150

121

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

75.6

980

4408

F11.2

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, dependence syndrome

96.5

75.1

121

Kela drug reimbursment

Severe hypofunction of sexual glands

5.0

75.0

257

468

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

74.0

1324

6723

30430

ICD-8 Finland

Drug dependence, Other hypnotics and sedatives or tranquillisers

+∞

73.8

ZXC86

NOMESCO Finland

Use of endoscopic device

13.5

73.2

133

P01

ICPC

Feeling anxious/nervous/tense

1.6

73.0

2064

12038

E29.1

ICD-10 Finland

Testicular hypofunction

6.3

72.7

205

295

N06AA09

ATC

amitriptyline; systemic

2.4

71.8

669

2583

N84.0

ICD-10 Finland

Polyp of corpus uteri

3.0

71.7

436

1308

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.0

71.7

449

1373

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

71.6

1399

7311

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

71.5

877

3850

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.1

71.4

917

4103

A46

ICD-10 Finland

Erysipelas

2.0

70.8

965

4424

N05BA02

ATC

chlordiazepoxide; systemic

4.4

70.3

269

550

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

2.2

70.0

765

3191

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

69.0

716

2914

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

68.8

IER01

NOMESCO Finland

Psychoeducation, group

6.1

68.8

198

293

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.6

68.7

251

490

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

26.2

68.6

N06AX05

ATC

trazodone; oral

3.4

68.6

351

928

Y28

ICPC

Limited function/disability (Y)

15.2

68.3

118

3071A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Anorexia nervosa

+∞

67.8

F50

ICD-10 Finland

Eating disorders

27.8

67.6

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

78.8

67.5

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

67.0

1809

10396

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.0

66.8

975

4590

LBE01

NOMESCO Finland

Laparoscopic salpingectomy

3.1

66.5

397

1174

SPAT1265

SPAT

Breathalyser

5.4

66.5

210

349

M79.6

ICD-10 Finland

Pain in limb

1.5

65.9

3235

21402

A06AD11

ATC

lactulose; oral

1.9

65.8

1022

4924

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

65.7

912

4207

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

65.7

1531

8434

S18

ICPC

Laceration/cut

1.5

65.5

3408

22816

F40.1

ICD-10 Finland

Social phobias

2.6

65.0

497

1722

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.8

64.9

294

703

P76

ICPC

Depressive disorder

1.9

64.7

1000

4807

F50.5

ICD-10 Finland

Vomiting associated with other psychological disturbances

109.1

64.6

Z71.8

ICD-10 Finland

Other specified counselling

1.5

64.5

2959

19286

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.8

64.5

1160

5884

R51.80

ICD-10 Finland

Headache

1.6

64.5

1951

11539

F93.89

ICD-10 Finland

Other childhood emotional disorders

3.8

64.4

290

690

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.1

64.2

381

1124

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

7.0

63.6

166

215

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.9

63.5

422

1342

N04AA02

ATC

biperiden; systemic

4.2

63.0

253

543

F34.1

ICD-10 Finland

Dysthymia

2.6

62.8

505

1801

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

7.5

62.8

156

188

G03DB01

ATC

dydrogesterone; oral

1.7

62.6

1426

7792

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.2

62.5

361

1042

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

62.5

1815

10612

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.0

61.9

378

1136

WX110

NOMESCO Finland

Local anesthesy

1.4

61.7

8134

64042

P74

ICPC

Anxiety disorder/anxiety state

2.1

61.6

723

3109

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

61.5

753

3295

R4190

NOMESCO Finland

Nutritional therapy

2.6

61.5

493

1755

N06AX03

ATC

mianserin; oral

2.9

61.5

403

1271

B01AB05

ATC

enoxaparin; parenteral

1.6

61.3

2117

12923

R06.0

ICD-10 Finland

Dyspnoea

1.6

61.2

1975

11859

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.0

61.1

380

1158

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

60.9

846

3899

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.1

60.8

362

1070

X78

ICD-10 Finland

Intentional self-harm by sharp object

5.6

60.5

187

303

F19.26

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction

34.6

60.2

XCK00

NOMESCO Finland

Perimetry

2.5

60.2

494

1781

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

60.2

1609

9195

F11.39

ICD-10 Finland

Withdrawal symptoms caused by opiates without information about seizures

554.3

60.1

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

5.7

60.0

181

285

SPAT1227

SPAT

Substance abuse rehabilitation

6.7

59.6

160

216

G02CB03

ATC

cabergoline; oral (prolactine inhibitors)

7.5

59.2

147

177

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

58.6

4306

30597

C07AB07

ATC

bisoprolol; oral

1.5

58.4

2743

17899

A02BC05

ATC

esomeprazole; systemic

1.4

58.2

3212

21646

P99

ICPC

Psychological disorders other

2.6

58.1

455

1597

G47.3

ICD-10 Finland

Sleep apnoea

1.6

58.0

1532

8719

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

4.8

57.8

202

377

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

57.8

1729

10170

T05

ICPC

Feeding problem of adult

5.1

57.7

193

343

N02AA05

ATC

oxycodone; systemic

2.0

57.6

855

4042

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.7

57.6

419

1408

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.3

57.5

311

858

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.6

57.3

434

1495

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.3

56.8

311

866

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.5

56.8

281

724

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.5

56.7

281

725

F10.24

ICD-10 Finland

Alcohol depence active use

4.4

56.7

216

441

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.6

56.5

446

1573

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.7

56.2

1419

7967

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.2

55.9

625

2626

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

55.8

R50.9

ICD-10 Finland

Fever, unspecified

1.6

54.9

1533

8842

C74.1

ICD-10 Finland

Malignant neoplasm: Medulla of adrenal gland

+∞

54.8

R63.0

ICD-10 Finland

Anorexia

12.6

54.7

102

F13.21

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment

50.8

54.6

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

54.2

1643

9680

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

54.1

2110

13200

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

53.9

784

3673

P15

ICPC

Chronic alcohol abuse

3.0

53.9

333

1010

3044A

ICD-9 Finland

Drug dependence, Amphetamine and other psychostimulant dependence

+∞

53.8

M54.5

ICD-10 Finland

Low back pain

1.4

53.7

3324

22817

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

3.7

53.7

250

613

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

4.5

53.3

198

394

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

+∞

52.8

C74.0

ICD-10 Finland

Malignant neoplasm: Cortex of adrenal gland

+∞

52.8

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.7

52.7

246

605

TLC02

NOMESCO Finland

Simple extraction of IUD

2.2

52.5

566

2340

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

3.7

52.4

240

581

N80.1

ICD-10 Finland

Endometriosis of ovary

2.4

52.4

475

1806

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.3

52.4

506

1987

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

52.2

1384

7868

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.8

52.1

350

1119

E34.35

ICD-10 Finland

Abnormal growth retardation

6.4

52.0

143

200

N06AA06

ATC

trimipramine; systemic

3.6

52.0

250

630

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

51.9

1650

9828

30499

ICD-8 Finland

Drug dependence, Unspecified

+∞

51.9

G03FB08

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

4.5

51.5

193

388

JAL30

NOMESCO Finland

Omentectomy

12.5

51.4

J01FF01

ATC

clindamycin; systemic

1.5

51.4

2449

15963

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.8

51.2

899

4510

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

50.5

828

4055

IGV01

NOMESCO Finland

Psychiatric network contact

4.0

50.3

211

473

N06AG02

ATC

moclobemide; oral

2.7

50.2

360

1200

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

2.3

50.1

517

2094

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.4

50.1

446

1679

H53.4

ICD-10 Finland

Visual field defects

4.1

50.1

208

462

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

50.0

998

5219

30488

ICD-8 Finland

Drug dependence, Other

+∞

49.9

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

49.7

1907

11860

J01DB01

ATC

cefalexin; oral

1.4

49.7

9306

75936

N06BA04

ATC

methylphenidate; oral

2.2

49.6

520

2122

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.0

49.3

305

926

F32.1

ICD-10 Finland

Moderate depressive episode

1.8

48.7

870

4387

RD210

NOMESCO Finland

3.0

48.6

306

939

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

48.6

386

1367

F19.59

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS

34.3

48.4

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

48.2

1739

10660

AA400

NOMESCO Finland

Electroconvulsive therapy

5.0

48.0

162

292

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.7

47.9

354

1202

128

Kela drug reimbursment

Cancers of female genital organs

9.1

47.8

105

104

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

47.8

1837

11422

SPAT1254

SPAT

Administration of medicine

1.6

47.7

1498

8881

N05AA01

ATC

chlorpromazine; systemic, rectal

4.6

47.7

174

341

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

47.6

1980

12522

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.9

47.3

204

469

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

47.3

2196

14207

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

47.3

2340

15334

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

14.7

47.2

ULC02

NOMESCO Finland

Hysteroscopy

2.5

47.1

403

1486

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

47.1

796

3938

E24.0

ICD-10 Finland

Pituitary-dependent Cushing disease

224.0

46.8

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.7

46.5

343

1164

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.6

46.5

370

1311

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

8.7

46.4

104

107

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

46.3

1226

6957

SPAT1307

SPAT

Psychosocial counselling and guidance

1.6

46.2

1260

7203

P03

ICPC

Feeling depressed

1.6

46.1

1503

8989

F19.09

ICD-10 Finland

Intoxication caused by several drugs in combination and by other psychoactive substances UNS

19.6

46.0

LAC01

NOMESCO Finland

Laparoscopic excision of ovarian cyst

2.9

46.0

292

903

C74.9

ICD-10 Finland

Malignant neoplasm: Adrenal gland, unspecified

+∞

45.9

339

Kela drug reimbursment

Product containing buprenorfine and naloxone

219.3

45.8

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

45.8

1190

6716

LBE00

NOMESCO Finland

Salpingectomy

8.5

45.7

104

110

A02BC03

ATC

lansoprazole; oral

1.5

45.6

1954

12420

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.2

45.6

254

718

R52.2

ICD-10 Finland

Other chronic pain

2.7

45.5

329

1103

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

45.5

1536

9259

WX892

NOMESCO Finland

Monitored bed care

2.0

45.5

608

2755

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

5.7

45.5

136

213

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.9

45.4

199

464

F11.26

ICD-10 Finland

Addiction caused by opiates intermittent drug addiction

419.0

45.2

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

45.2

3380

23818

N06AB08

ATC

fluvoxamine; oral

3.2

45.1

248

694

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

45.1

5792

44305

E87.6

ICD-10 Finland

Hypokalaemia

3.5

45.0

223

577

WX002

NOMESCO Finland

Sedation and analgesia

1.6

44.9

1367

8036

3043A

ICD-9 Finland

Drug dependence, Cannabis dependence

+∞

44.9

F19.50

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances schizophrenic

28.2

44.8

N03AF01

ATC

carbamazepine; oral, rectal

2.4

44.7

393

1471

T40.9

ICD-10 Finland

Poisoning: Other and unspecified psychodysleptics [hallucinogens]

16.0

44.7

T40.6

ICD-10 Finland

Poisoning: Other and unspecified narcotics

22.2

44.6

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

2.8

44.5

298

953

R42

ICD-10 Finland

Dizziness and giddiness

1.5

44.5

1579

9627

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

44.4

3360

23706

L03

ICPC

Low back symptom/complaint

1.4

44.4

2357

15629

J01MA12

ATC

levofloxacin; systemic

1.6

44.3

1304

7600

F15.3

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state

30.4

44.2

F19.22

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication

30.4

44.2

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

44.2

4464

32943

F41.00

ICD-10 Finland

Moderate panic disorder

2.7

44.2

327

1111

F12.29

ICD-10 Finland

Addiction caused by cannabis UNS

14.8

43.9

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

43.9

606

2781

E89.30

ICD-10 Finland

Postprocedural hypopituitarism

+∞

43.9

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

12.0

43.8

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

4.4

43.7

167

343

A04

ICPC

Weakness/tiredness general

1.5

43.7

1459

8769

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

43.6

672

3217

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

43.5

5323

40359

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

3.7

43.4

197

474

F15.0

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, acute intoxication

24.5

43.2

N06AX22

ATC

agomelatine; oral

2.6

43.2

342

1208

R03AC02

ATC

salbutamol; inhalant

1.3

43.2

5534

42214

E24.9

ICD-10 Finland

Cushing syndrome, unspecified

36.4

43.1

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

4.7

43.1

153

292

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.5

42.7

366

1352

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.8

42.4

285

914

F12.25

ICD-10 Finland

Dependence caused by cannabis continuous use

19.7

42.3

P72

ICPC

Schizophrenia

3.2

42.2

236

669

R63.4

ICD-10 Finland

Abnormal weight loss

2.9

42.1

269

835

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.3

42.1

409

1608

B17.1

ICD-10 Finland

Acute hepatitis C

13.7

42.0

JN4BD

NOMESCO Finland

Extensive body CT

2.0

42.0

605

2823

R11

ICD-10 Finland

Nausea and vomiting

1.7

41.9

905

4838

L28

ICPC

Limited function/disability (L)

1.7

41.8

899

4798

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

9.0

41.8

E34.39

ICD-10 Finland

Short stature, not elsewhere classified

7.7

41.8

101

118

T08

ICPC

Weight loss

3.7

41.8

191

463

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.2

41.7

465

1951

S06.0

ICD-10 Finland

Concussion

1.6

41.5

1116

6349

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.1

41.3

497

2157

F12.21

ICD-10 Finland

Dependence caused by cannabis currently independent but staying in a controlling environment

30.0

41.2

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.9

41.2

615

2908

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.4

41.1

209

552

E66.00

ICD-10 Finland

Metabolic syndrome

2.3

41.1

409

1629

R4110

NOMESCO Finland

Physiotherapy

1.4

41.1

2080

13642

A01

ICPC

Pain general/multiple sites

1.9

41.0

653

3159

T99

ICPC

Endocr/metab/nutrit disease other

4.1

41.0

166

361

D35.31

ICD-10 Finland

Cyst in Rathke's pocket

16.5

41.0

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

9.8

41.0

2200A

ICD-9 Finland

Benign neoplasm of ovary[NEOPLASMA BENIGNUM OVARII]

+∞

40.9

F11.23

ICD-10 Finland

Addiction-induced dependence is currently independent but uses aversion-inducing medication

+∞

40.9

D35.30

ICD-10 Finland

Craniopharyngoma

134.2

40.8

IER03

NOMESCO Finland

Psychiatric disorder-specific group intervention

6.7

40.7

108

145

R4140

NOMESCO Finland

Psychotherapy

4.3

40.6

157

327

Z86.4

ICD-10 Finland

Personal history of psychoactive substance abuse

5.2

40.5

131

226

IEV99

NOMESCO Finland

Other psychiatric network intervention

4.6

40.4

147

288

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

40.3

824

4330

D39.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Uterus

14.6

40.3

A02BC01

ATC

omeprazole; systemic

1.4

40.2

2199

14625

M03BX02

ATC

tizanidine; oral

1.3

40.2

5968

46265

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

4.4

40.2

152

310

L17

ICPC

Foot/toe symptom/complaint

1.4

40.1

2082

13713

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

40.0

1587

9899

F11.09

ICD-10 Finland

Intoxication caused by opiates UNS

+∞

39.9

SPAT1197

SPAT

Extensive health check-up of expecting family

0.7

39.8

1882

22167

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.2

39.8

129

223

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

39.8

1507

9305

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

39.6

554

2555

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.9

39.5

259

819

J01DA01

ATC

[U] cefalexin; systemic

1.3

39.3

6317

49422

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.9

39.1

660

3259

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.0

39.1

533

2431

UJF32

NOMESCO Finland

Coloscopy

1.5

39.1

1564

9773

N05AF05

ATC

zuclopenthixol; systemic

5.2

39.0

127

221

T74.1

ICD-10 Finland

Physical abuse

2.5

38.9

332

1224

E23.08

ICD-10 Finland

Hypopituitarism

+∞

38.9

F11.00

ICD-10 Finland

Intoxication caused by opiates uncomplicated

+∞

38.9

C03CA01

ATC

furosemide; systemic

1.5

38.6

1329

8025

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

38.5

583

2768

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

38.5

421

1753

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.5

38.1

305

1086

Q50.10

ICD-10 Finland

A developmental cyst in the ovary

3.3

38.1

198

533

R02

ICPC

Shortness of breath/dyspnoea

1.6

37.9

997

5629

105

Kela drug reimbursment

Adrenal cortical hypofunction

10.5

37.7

K08.3

ICD-10 Finland

Retained dental root

2.0

37.6

492

2210

EBA30

NOMESCO Finland

Excision of root of tooth

2.2

37.6

390

1585

R5599

NOMESCO Finland

Other rehabilitation service

2.7

37.3

275

934

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

6.8

37.3

130

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

37.3

801

4275

RS220

NOMESCO Finland

3.2

37.2

204

571

F41.3

ICD-10 Finland

Other mixed anxiety disorders

2.6

36.9

276

945

2180A

ICD-9 Finland

Uterine leiomyoma, Submucous leiomyoma of uterus

+∞

36.9

E23.0

ICD-10 Finland

Hypopituitarism

+∞

36.9

F60.8

ICD-10 Finland

Other specific personality disorders

4.2

36.8

145

308

IEY01

NOMESCO Finland

Psychoeducation, individual

3.7

36.7

167

404

A28

ICPC

Limited function/disability NOS

1.8

36.7

690

3532

A02BA02

ATC

ranitidine; systemic

1.6

36.6

1182

7028

X84

ICD-10 Finland

Intentional self-harm by unspecified means

7.0

36.6

121

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

36.5

372

1500

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

36.5

693

3558

F12.24

ICD-10 Finland

Addiction caused by cannabis active addiction

21.4

36.3

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

36.3

1199

7168

P06

ICPC

Sleep disturbance

1.6

36.2

1030

5938

22099

ICD-8 Finland

Benign neoplasm of ovary, Other and unspecified

+∞

35.9

A41.9

ICD-10 Finland

Sepsis, unspecified

2.6

35.8

273

946

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

35.6

2823

19932

SPAT1260

SPAT

Consultation of another employee

1.4

35.6

1646

10577

W78

ICPC

Pregnancy

0.7

35.4

2217

25103

2273A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)

328.9

35.4

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

35.2

2236

15227

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

35.1

8285

67588

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

35.1

485

2224

N07BC51

ATC

buprenorphine, combinations; sublingual

169.9

35.1

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

35.0

435

1912

P16

ICPC

Acute alcohol abuse

3.1

35.0

203

593

E23.6

ICD-10 Finland

Other disorders of pituitary gland

116.3

35.0

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.7

34.9

250

836

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

34.9

599

2975

F31

ICD-10 Finland

Bipolar affective disorder

3.1

34.8

200

580

N05AB01

ATC

dixyrazine; systemic

5.0

34.6

116

209

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

6.4

34.6

131

IFC99

NOMESCO Finland

Other biological psychiatric intervention

12.5

34.6

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

34.5

2323

15962

SPAT1153

SPAT

Removal of sutures

1.4

34.4

2246

15354

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

34.4

498

2326

F12.20

ICD-10 Finland

Dependence caused by cannabis currently independent

13.7

34.3

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

34.3

1015

5905

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

34.2

3452

25220

N03AX11

ATC

topiramate; oral

2.2

34.1

360

1475

B01AB10

ATC

tinzaparin; parenteral

2.1

34.1

424

1867

E25.9

ICD-10 Finland

Adrenogenital disorder, unspecified

113.3

34.0

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

34.0

2270

15574

F32

ICD-10 Finland

Depressive episode

1.7

33.9

708

3742

C56.91

ICD-10 Finland

Malignant granulosa cell tumor in ovary

+∞

33.9

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(4281824)

1147

1916

3.83

318.82

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

576

503

7.26

311.97

1.7

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

721

686

6.68

307.65

1.7

1.2

mu/l

997.0

384.4

3.23

687

647

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

1862

1077

11.29

307.65

3.0

1.6

nmol/l

19.6

20.3

1.24

1799

1014

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

20275

97513

1.58

307.65

6.7

6.0

mmol/l

1.2

0.47

17073

82463

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

5149

12862

2.72

307.65

4.5

2.3

u/ml

62.5

41.3

2.41

5002

12384

(3023103) Potassium [Moles/volume] in Serum or Plasma

38255

218116

2.08

307.65

16.7

13.0

mmol/l

3.9

11.80

37405

211798

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

30143

159115

1.66

307.65

7.7

6.9

u/l

77.2

76.6

1.37

28361

149943

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

2658

5341

3.26

307.65

1.5

1.4

pmol/l

155.6

95.5

5.71

2597

5197

(3009214) Lutropin [Units/volume] in Serum or Plasma

2740

6742

2.65

307.65

1.8

1.3

u/l

9.3

11.3

9.21

2200

5499

(3036481) Cortisol [Moles/volume] in Serum or Plasma

6211

19421

2.18

307.65

3.0

1.9

nmol/l

362.3

379.1

6.91

5750

17835

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

729

708

6.55

307.65

1.7

1.2

73.9

72.2

1.79

695

669

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

18546

87596

1.58

307.65

6.1

5.4

mmol/l

1.2

1.64

16817

79601

(3021387) Prolactin [Units/volume] in Serum or Plasma

3547

9889

2.36

307.65

2.8

1.3

mu/l

378.7

298.8

10.42

3282

8785

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

20875

103575

1.52

307.65

6.0

5.6

umol/l

10.1

10.5

4.71

19662

97563

(3024561) Albumin [Mass/volume] in Serum or Plasma

17707

84102

1.55

307.65

4.6

4.5

g/l

36.0

36.1

0.83

16399

77928

(3035637) Corticotropin [Mass/volume] in Plasma

1301

2235

3.73

307.65

2.0

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

38185

217511

2.07

307.65

16.6

12.9

mmol/l

139.6

0.32

37399

211684

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

32634

179579

1.62

307.65

5.0

4.2

pmol/l

14.6

3.37

30120

165798

(40768804) Tissue Pathology biopsy report

18330

88059

1.54

307.65

2.2

2.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

807

427

12.06

307.65

3.2

1.7

ug/l

1.1

1.4

1.27

754

410

(3015377) Calcium [Moles/volume] in Serum or Plasma

14427

68429

1.49

278.57

3.3

3.2

mmol/l

2.4

1.77

12558

60409

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

387

221

11.07

278.17

1.9

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

36155

206636

1.68

275.92

5.9

4.9

mu/l

2.0

2.1

0.21

33591

193002

(3013826) Glucose [Moles/volume] in Serum or Plasma

22462

116526

1.45

269.78

4.8

4.2

mmol/l

6.5

0.09

21071

106820

(3044640) Blood type and Crossmatch panel - Blood

13762

64992

1.49

269.03

2.4

2.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1154

2191

3.37

267.37

2.9

1.7

pmol/l

165.5

174.7

1.50

1114

2076

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

35163

200022

1.62

264.57

13.4

10.7

ml/min/173m2

84.8

86.0

21.99

29440

162639

(3018418) pH of Serum or Plasma

12384

58189

1.47

242.10

4.1

3.7

7.4

2.56

2407

10816

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

416

335

7.85

239.59

3.2

1.4

ng/l

95.3

113.2

0.56

235

178

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2596

7922

2.12

239.05

4.6

1.8

nmol/l

10.4

10.6

0.68

2349

6989

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

19549

100188

1.42

238.30

4.0

3.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

33361

188740

1.52

236.38

5.6

4.9

mmol/mol

38.9

38.6

10.37

30811

176589

(3013707) Erythrocyte sedimentation rate by Westergren method

29175

160752

1.45

235.87

4.2

3.9

mm/h

11.5

11.3

1.14

27131

150010

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

35637

204636

1.59

235.86

4.6

4.0

mmol/l

5.8

5.7

17.18

32667

189599

(3032080) INR in Blood by Coagulation assay

14532

71200

1.43

223.09

7.4

7.0

inr

1.1

1.2

1.08

4465

21613

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

15954

79532

1.41

221.99

2.0

1.9

pmol/l

99.6

98.2

2.50

7988

40578

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

18178

92881

1.40

218.15

2.5

2.3

nmol/l

5069.0

76.8

0.50

16425

85130

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6995

29640

1.57

217.97

3.6

3.3

mmol/l

0.8

0.83

6501

27561

(3044889) 12 lead EKG panel

25869

140359

1.40

217.39

3.6

3.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

26471

144325

1.40

214.86

4.9

4.3

e6/l

1301.5

1888.2

1.40

313

1726

(3020564) Creatinine [Moles/volume] in Serum or Plasma

38953

229949

1.82

214.23

16.9

13.2

umol/l

70.1

70.5

2.14

38938

229837

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

10461

48547

1.47

211.93

2.3

2.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1453

3607

2.58

211.82

2.7

1.5

nmol/l

39.2

43.6

5.01

1399

3544

(3028707) Methadone [Presence] in Urine by Screen method

1687

4510

2.40

211.04

7.3

1.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

13129

63693

1.42

209.41

2.7

2.4

u/l

56.9

57.6

0.40

12014

58835

(3013650) Neutrophils [#/volume] in Blood by Automated count

23220

124330

1.38

204.93

10.1

8.5

e9/l

4.0

0.40

20306

109107

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4447

17134

1.70

200.45

2.4

2.3

g/l

0.2

1.06

4138

15996

(3013512) EKG study

10949

51885

1.44

195.66

3.8

3.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5623

23216

1.60

193.14

5.6

5.5

mmol/l

1.1

0.49

5212

21618

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

39036

231741

1.76

185.77

11.3

9.3

u/l

25.9

24.9

6.72

37761

224334

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1289

3217

2.56

185.68

2.4

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

665

1129

3.73

180.48

1.9

1.3

—

(3033658) Prothrombin time (PT) actual/Normal

10503

50266

1.41

173.54

4.0

3.7

95.7

94.3

7.22

10201

48868

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

11644

56802

1.39

171.88

2.2

2.0

u/l

187.8

179.8

0.19

10930

53290

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13876

69703

1.37

171.22

3.5

3.1

u/l

33.5

31.7

0.81

13152

66266

(3037467) Urinalysis macro (dipstick) panel - Urine

26977

150387

1.35

163.36

4.8

4.2

—

(3007463) Buprenorphine [Presence] in Urine

154

30.26

162.56

9.9

2.1

—

(42870588) Differential panel, method unspecified - Blood

14043

71129

1.36

161.93

6.1

5.9

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

37375

220513

1.55

161.75

14.8

12.0

mg/l

21.2

20.8

1.21

30039

170749

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

251

173

9.14

161.08

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

3991

15838

1.64

158.59

1.5

1.3

iu/l

24.7

28.1

8.41

3396

13735

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

13727

69593

1.35

155.68

3.5

3.1

ng/l

30.4

59.4

2.33

8327

39660

(3019309) Folate [Moles/volume] in Red Blood Cells

7350

33506

1.45

155.67

1.8

1.7

nmol/l

1183.7

1183.1

0.02

5543

25687

(3013115) Eosinophils [#/volume] in Blood

20743

111741

1.32

155.00

6.5

6.0

e9/l

0.2

1.82

18258

99174

(3023368) Bacteria identified in Blood by Culture

9748

46830

1.40

154.15

4.6

3.9

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

10514

51160

1.38

154.04

2.4

2.2

mg/l

3.0

2.8

9.20

8962

44023

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1535

4517

2.17

153.36

1.6

1.4

nmol/l

0.3

0.5

5.30

1169

3581

(3006315) Basophils [#/volume] in Blood

20122

108027

1.32

153.33

6.2

5.8

e9/l

0.0

0.77

17400

94391

(3001604) Monocytes [#/volume] in Blood

20048

107587

1.32

153.10

6.2

5.8

e9/l

0.5

0.6

0.72

17383

94089

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4270

17445

1.59

150.37

3.2

3.9

ug/l

18.2

23.8

0.62

3228

13570

(3009508) Creatinine [Moles/volume] in Urine

11418

56515

1.37

149.67

4.1

3.1

mmol/l

7.0

7.5

1.40

9505

48259

(3019198) Lymphocytes [#/volume] in Blood

20595

111316

1.31

146.80

6.2

5.8

e9/l

2.0

0.50

18203

99114

(3002256) Pathology report gross observation

5992

26537

1.48

145.95

1.3

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

510

833

3.87

145.76

2.0

1.4

iu/ml

2337766.8

2048969.9

0.15

(3019069) Monocytes/100 leukocytes in Blood

18969

101462

1.31

145.21

6.6

6.2

8.2

8.3

0.87

17707

95467

(3006504) Eosinophils/100 leukocytes in Blood

18861

100954

1.31

142.69

6.3

5.9

2.8

1.23

17504

94390

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

36258

213575

1.46

141.90

4.8

4.3

mmol/l

2.9

0.98

33345

199499

(3022096) Basophils/100 leukocytes in Blood

18303

97729

1.31

139.92

6.4

6.0

0.7

0.46

16977

91372

(3021960) Folate [Moles/volume] in Serum or Plasma

9033

43472

1.38

138.83

1.6

1.5

nmol/l

20.8

21.0

0.75

7710

37729

(3002030) Lymphocytes/100 leukocytes in Blood

19473

105001

1.30

137.48

6.4

5.9

29.1

29.2

0.45

18093

98330

(3042517) Benzodiazepines panel - Urine

251

228

6.93

131.83

4.8

1.7

—

(3018010) Neutrophils/100 leukocytes in Blood

19169

103542

1.29

131.03

6.2

5.8

56.5

0.21

17883

97321

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

9484

46395

1.36

130.35

2.9

2.8

ng/l

1104.7

1198.4

1.00

7875

38927

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1815

20025

0.55

129.25

1.4

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

35726

210569

1.42

129.09

4.4

3.9

mmol/l

4.8

5.71

33062

197819

(3011288) Drugs identified in Urine by Screen method

2126

7486

1.82

128.12

9.2

1.9

—

(3021589) Normoblasts [#/volume] in Blood

17827

95660

1.29

126.49

10.1

8.6

e9/l

0.0

0.95

14647

78451

(40761511) CBC panel - Blood by Automated count

38598

231213

1.55

124.78

14.3

11.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

35468

209071

1.40

124.11

4.4

3.9

mmol/l

1.5

0.28

32630

195804

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3833

15960

1.56

122.95

3.3

pmol/l

4.4

4.5

5.14

3438

14266

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

34310

201236

1.37

122.50

4.0

3.5

mmol/l

1.3

1.2

72.17

31332

187627

(3026782) Osmolality of Urine

7849

37625

1.38

121.01

2.9

2.6

mosm/kgh2o

516.4

528.0

3.61

6684

31809

(3026008) Bacteria identified in Urine by Culture

12840

66293

1.31

119.98

3.2

2.9

—

(3030467) Casts [#/volume] in Urine by Automated count

10712

53968

1.33

119.03

3.2

2.9

e6/l

0.4

0.65

8009

39832

(4035726)

3967

16787

1.53

118.07

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

11542

58910

1.31

116.44

3.3

3.0

e6/l

96.3

66.0

1.08

8764

44119

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4275

18439

1.50

116.26

3.4

3.0

—

(3018095) Leukocytes [#/volume] in Urine

13802

72185

1.29

116.10

3.9

3.4

e6/l

94.2

96.2

0.09

9535

48363

(4198724)

528

1044

3.20

114.74

3.2

1.8

—

(36304419) Bacteria [Presence] in Urine

10561

53470

1.32

111.95

3.1

2.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

26081

148029

1.27

111.01

3.5

2.9

u/l

43.4

40.3

6.02

24418

139768

(3022948) Iron [Moles/volume] in Serum or Plasma

6459

30369

1.39

110.62

2.4

2.3

umol/l

13.4

13.5

0.84

5941

28137

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7356

35716

1.35

102.25

2.7

2.8

mmol/l

2.4

3.06

6410

31070

(3008295) Osmolality of Serum or Plasma

702

1747

2.54

101.48

2.2

1.4

mosm/kgh2o

282.5

278.8

3.82

580

1337

(3019225) pH of Specimen

4135

18249

1.47

99.41

4.0

3.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

19625

108544

1.25

98.32

5.3

4.8

estimate

0.0

0.10

3953

20574

(3009261) Glucose [Presence] in Urine by Test strip

19789

109554

1.25

98.32

4.0

3.5

estimate

0.0

0.07

3928

20314

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5437

25286

1.40

98.10

2.5

2.4

22.2

22.8

1.92

4652

21700

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5869

27670

1.38

97.61

2.4

2.3

g/l

2.4

0.94

5352

25580

(40758558) Short blood count panel - Blood

10538

54157

1.29

97.21

7.5

6.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

19219

106189

1.25

96.40

3.2

2.8

ug/l

93.8

91.4

0.76

17845

99687

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

8327

41498

1.32

96.17

1.7

1.6

pmol/l

28126811.5

38232202.5

0.88

6901

34950

(3015736) pH of Urine

15522

83812

1.25

94.89

3.9

3.3

5.8

5.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1398

4736

1.88

94.62

1.5

1.3

u/l

23.4

27.0

3.67

1178

3862

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3367

14400

1.51

94.24

3.6

ng/l

84.8

81.7

0.85

2869

12571

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

9438

48105

1.30

91.71

1.8

mg/l

1.0

1.1

0.46

7067

36137

(3003396) Base excess in Arterial blood by calculation

4120

18465

1.44

90.88

6.9

mmol/l

1.0

1.1

1.33

3296

14391

(3050129) First trimester maternal screen panel - Serum or Plasma

1172

13312

0.54

90.73

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

10081

51936

1.28

89.83

4.0

3.9

mg/mmol

9.6

9.3

0.16

5928

31622

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4109

18454

1.44

89.55

6.9

kpa

5.1

4.70

3924

17586

(3027801) Oxygen [Partial pressure] in Arterial blood

4107

18447

1.44

89.45

6.9

kpa

13.1

12.8

1.30

3917

17581

(3000850) Epithelial cells [#/volume] in Urine

8114

40749

1.31

87.38

2.7

2.5

e6/l

7.4

7.3

0.06

7043

35373

(3012516) Albumin [Mass/volume] in Urine

9644

49559

1.28

87.17

3.2

mg/l

478.2

454.2

0.16

5650

29906

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

10215

52902

1.28

86.72

1.7

1.6

mmol/l

1.4

1.3

19.32

8600

45376

(3014576) Chloride [Moles/volume] in Serum or Plasma

4584

21141

1.40

85.91

6.9

6.7

mmol/l

104.5

104.4

0.28

4497

20695

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4883

22822

1.39

84.50

4.4

4.0

32.6

32.7

0.31

3409

16142

(3042936) Bacteria identified in Isolate by Culture

5531

26395

1.36

84.10

2.0

1.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

4001

33939

0.71

83.29

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

19377

108265

1.23

82.01

4.0

3.5

estimate

0.0

0.81

3907

20075

(3014111) Lactate [Moles/volume] in Serum or Plasma

3366

14841

1.46

80.39

6.8

mmol/l

1.3

1.53

3230

14301

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6009

29258

1.33

79.62

1.9

1.8

—

(3007461) Platelets [#/volume] in Blood

40446

247217

1.64

79.45

23.1

17.6

e9/l

266.0

261.5

34.55

39635

241311

(40768797) Stomach Pathology biopsy report

5820

28285

1.34

77.93

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2134

8599

1.58

77.50

6.6

1.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

430

953

2.85

77.40

2.1

1.4

nmol/l

4.1

11.1

0.58

371

767

(3035941) MCH [Entitic mass]

40456

247410

1.63

76.99

22.9

17.5

30.0

30.1

29.76

40016

244394

(3024731) MCV [Entitic volume]

40458

247433

1.63

76.83

23.0

17.5

90.5

1.41

40017

244409

(3026361) Erythrocytes [#/volume] in Blood

40460

247457

1.63

76.65

23.0

17.5

e12/l

4.5

10.93

39550

241017

(3010813) Leukocytes [#/volume] in Blood

40464

247522

1.62

75.93

23.1

17.6

e9/l

6.7

0.85

39552

241033

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

837

9961

0.52

75.23

1.4

1.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

40462

247550

1.62

75.03

23.2

17.6

g/l

132.7

133.9

61.22

40033

244574

(3027945) Reticulocytes/100 erythrocytes in Blood

4042

18734

1.39

72.78

2.7

2.6

1.8

0.41

3523

16618

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6152

30415

1.31

72.54

2.8

2.7

e6/l

4.3

0.00

3207

15834

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5486

26704

1.33

72.14

2.0

1.6

1.4

14.35

4863

23887

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2587

11080

1.49

71.14

7.1

7.3

mmol/l

24.9

24.8

1.00

2568

10986

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

757

2316

2.07

68.28

1.5

1.3

nmol/l

33.2

26.4

0.44

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6534

32826

1.29

67.89

2.7

2.5

e6/l

1.3

0.07

3582

18113

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4055

19014

1.37

67.74

2.5

2.4

u/l

35.4

41.2

1.15

3486

16262

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3424

15611

1.41

67.59

3.9

3.4

mmol/l

1.2

0.11

2979

13615

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

768

9048

0.52

66.65

1.7

1.8

—

(3011985) Renin [Units/volume] in Plasma

825

2633

1.98

66.38

2.0

1.5

mu/l

61.0

59.3

0.08

752

2356

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1039

11195

0.57

65.97

1.4

1.5

—

(3000991) Gas panel - Venous blood

3210

14542

1.41

65.62

8.4

8.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3327

15224

1.40

64.16

7.7

g/l

120.4

120.5

0.16

3216

14656

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4791

23255

1.33

63.56

2.7

umol/l

6.6

7.3

1.60

4015

19742

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4033

19153

1.35

61.81

3.9

4.0

u/l

238.1

240.0

0.33

3773

18104

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5539

27535

1.30

61.74

2.3

2.2

29.5

29.4

0.21

5368

26684

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

980

10518

0.57

61.21

1.4

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

490

1309

2.36

61.20

20.1

17.7

nmol/l

1415.5

3907.9

1.02

470

1249

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

973

10460

0.57

61.15

1.4

—

(3016502) Oxygen saturation in Arterial blood

3514

16354

1.38

61.13

7.4

7.3

95.9

0.08

3394

15686

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

980

10512

0.57

61.07

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

979

10493

0.57

60.82

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3461

16137

1.37

59.46

4.7

4.0

kpa

5.9

5.8

2.00

3366

15653

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4751

23250

1.32

59.19

6.8

6.1

—

(3002032) Base excess in Venous blood by calculation

3444

16083

1.37

58.55

4.8

4.0

mmol/l

2.0

1.9

0.32

2866

13145

(3012544) pH of Venous blood

3543

16636

1.37

58.19

4.7

4.0

7.4

1.10

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1090

3975

1.74

57.89

1.5

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

10433

56178

1.22

57.55

1.3

u/ml

1.3

1.6

1.55

2789

15573

(3024354) Oxygen [Partial pressure] in Venous blood

2929

13355

1.40

57.40

4.1

3.5

kpa

4.6

0.05

2835

12928

(3007853) Bacteria identified in Skin by Aerobe culture

4908

24221

1.31

57.39

1.8

1.7

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

464

1246

2.35

57.33

15.0

12.5

nmol/l

813.9

1628.9

0.51

455

1201

(3023520) Reticulocytes [#/volume] in Blood

2956

13516

1.40

56.98

2.6

e9/l

71.7

70.1

1.36

2149

10026

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

503

1419

2.24

55.56

3.6

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

9272

49539

1.22

54.74

2.4

2.3

umol/l

3368.4

3756.6

0.48

7935

43509

(3016879) Cocaine [Presence] in Urine

2333

10295

1.44

54.74

6.5

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

8946

47624

1.22

54.73

1.5

1.4

g/l

2.2

2.16

5299

29237

(3009343) pH of Capillary blood

2421

10771

1.43

54.36

3.9

3.7

7.4

1.25

358

1325

(3020779) Urea [Moles/volume] in Serum or Plasma

3088

14339

1.38

54.18

7.6

7.3

mmol/l

8.4

8.7

2.10

2931

13679

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2440

10899

1.43

53.58

3.9

3.7

kpa

5.2

5.1

3.36

2270

10105

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

645

7493

0.53

53.28

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

761

2553

1.88

53.02

1.5

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2344

10420

1.43

52.82

3.9

3.7

mmol/l

1.9

1.7

2.65

1759

7603

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

822

2833

1.83

52.69

1.5

1.2

nmol/l

0.8

1.4

0.57

790

2733

(3022145) Colonoscopy Study observation

4569

22603

1.30

52.09

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2269

10064

1.44

51.73

1.7

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

815

2829

1.82

51.07

1.5

1.2

nmol/l

0.4

0.2

0.96

148

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2258

10066

1.43

50.05

8.3

8.9

0.7

0.14

2246

10002

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4041

19791

1.31

49.46

1.8

1.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

7870

41748

1.22

48.98

1.3

iu/ml

31.3

32.5

0.10

2433

13170

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2251

10105

1.42

47.96

8.3

8.8

1.4

2.01

2239

10039

(3014007) Fractional oxyhemoglobin in Arterial blood

2250

10108

1.42

47.74

8.4

8.9

94.0

94.1

0.16

2243

10066

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2993

14112

1.35

47.46

1.7

1.6

—

(3003181) Sodium [Moles/volume] in Urine

851

3064

1.76

47.27

1.7

1.4

mmol/l

67.3

62.5

2.02

683

2408

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4052

19971

1.30

47.20

1.8

1.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

835

8726

0.59

46.83

1.4

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

809

8522

0.59

46.82

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

2447

11200

1.39

46.60

6.4

1.5

—

(3005033) Fetal Nuchal fold Thickness US

809

8507

0.59

46.49

1.4

—

(3028300) Cannabinoids [Presence] in Urine

2457

11289

1.39

45.71

6.5

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

4285

21360

1.29

45.68

21.3

20.0

inr

1.2

0.23

615

3231

(3027008) Opiates [Presence] in Urine

2449

11260

1.39

45.37

6.2

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1893

8321

1.45

45.18

8.4

9.3

mmol/l

24.3

24.4

0.27

1776

7793

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

346

909

2.40

44.96

3.0

2.1

umol/l

176.3

152.3

0.46

177

472

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

7468

39714

1.22

44.78

1.3

u/ml

8.6

11.3

2.18

2858

16056

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

464

1399

2.09

43.63

12.1

11.9

mmol/l

0.6

0.24

423

1288

(3002385) Erythrocyte distribution width [Ratio]

31418

188205

1.18

43.28

18.5

14.3

13.7

13.6

26.93

30851

184349

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6731

35547

1.22

43.04

3.5

3.4

ng/l

281.0

376.3

1.05

4543

24039

(3011397) Hemoglobin [Presence] in Urine by Test strip

9307

50753

1.19

42.33

3.8

3.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

704

2479

1.79

42.17

1.4

1.3

pmol/l

343.1

325.8

0.28

552

1950

(3037522) Nuclear Ab [Titer] in Serum

6181

32474

1.23

41.39

1.4

titre

489.2

585.9

4.01

1283

6722

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

14829

84133

1.16

41.21

4.2

3.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1789

15553

0.71

41.10

3.9

3.6

22.5

21.7

1.17

692

6454

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1350

5672

1.51

40.38

1.4

ug/g

288.8

287.7

0.06

746

3174

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

392

4869

0.50

40.12

1.2

—

(3019060) Gas panel - Arterial blood

2262

10471

1.37

40.10

5.1

4.5

—

(3029937) Albumin [Presence] in Urine by Test strip

10465

57905

1.18

39.62

4.4

3.9

estimate

0.0

0.62

3930

20207

(40761536) Microorganisms panel - Urine sediment

3753

18716

1.28

39.55

4.4

3.7

—

(3036180) Methadone [Presence] in Urine

11.29

39.55

3.8

2.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

14.34

39.53

3.2

1.1

mu/l

2.0

3.9

0.72

(3020630) Protein [Mass/volume] in Serum or Plasma

2822

13585

1.32

38.65

2.7

2.4

g/l

66.3

66.8

2.19

2525

12328

(3010421) pH of Blood

1143

4678

1.55

38.57

3.7

3.6

7.4

3.06

972

3922

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1336

5656

1.50

38.53

2.2

2.3

ug/l

448.2

462.6

0.06

1209

5188

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1930

8766

1.40

38.32

5.7

4.4

mmol/l

24.3

24.2

0.40

1767

7928

(21494755) Public health laboratory ask at order entry panel

3386

26505

0.78

37.07

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

3259

16092

1.29

37.00

2.7

g/l

10.2

10.5

3.69

2933

14783

(3020191) Ethanol [Moles/volume] in Serum or Plasma

466

1500

1.96

36.80

1.6

1.5

promille

1.2

1.4

1.77

356

1127

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

556

1906

1.84

36.38

3.8

2.9

nmol/l

5.8

7.5

0.23

530

1838

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

510

1700

1.89

36.38

1.2

1.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

200

444

2.83

36.20

1.9

1.4

nmol/l

0.2

0.3

1.41

154

314

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1733

7804

1.41

36.14

3.7

3.0

1.4

1.3

2.31

1720

7763

(3027944) Amphetamines [Presence] in Urine

2348

11112

1.34

36.07

5.9

1.5

—

(3013290) Carbon dioxide [Partial pressure] in Blood

994

4014

1.57

35.60

3.8

3.7

kpa

5.1

5.0

3.76

973

3921

(3023183) Ammonium ion [Moles/volume] in Plasma

851

3313

1.62

35.49

2.8

umol/l

33.7

33.8

0.03

720

2826

(3012501) Base excess in Blood by calculation

993

4013

1.56

35.45

3.8

3.7

mmol/l

2.5

0.22

708

2634

(3017181) Myelocytes/100 leukocytes in Blood

3379

16853

1.28

35.39

4.1

1.0

0.9

1.07

958

4193

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

865

3388

1.61

35.21

1.2

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2146

10063

1.35

34.99

4.0

3.3

g/l

128.4

128.6

0.12

2085

9840

(3027315) Oxygen [Partial pressure] in Blood

996

4044

1.56

34.84

3.9

3.7

kpa

8.8

0.08

975

3950

(40760892) CBC W Ordered Manual Differential panel - Blood

9195

50777

1.17

34.82

4.5

4.2

—

(3022313) Gas panel - Capillary blood

1711

7744

1.40

34.65

4.1

4.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2164

10219

1.34

33.68

7.3

6.4

mmol/l

24.8

24.6

1.15

2034

9488

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1689

7668

1.40

33.59

3.7

3.0

0.6

0.7

2.16

1634

7335

(3021440) Promyelocytes/100 leukocytes in Blood

3224

16105

1.28

33.27

4.2

4.1

0.1

0.57

883

3887

(1616796) Gas panel - Central venous blood

955

3888

1.55

33.03

3.6

3.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

3095

15409

1.28

32.79

3.8

3.9

0.7

0.6

0.21

689

3036

(3009466) Valproate [Moles/volume] in Serum or Plasma

748

2883

1.64

32.50

5.7

5.2

umol/l

370.0

375.4

0.37

637

2543

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1358

5971

1.44

32.32

2.8

3.4

u/ml

362.5

1785.9

2.15

1138

5049

(3048689) Calprotectin [Mass/mass] in Stool

5793

30931

1.20

32.07

2.2

2.4

ug/g

117.0

119.1

0.13

4478

24168

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2311

11118

1.32

31.65

1.6

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

10718

60258

1.15

31.46

3.6

3.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

469

1608

1.84

30.76

1.5

1.3

umol/l

4.7

5.4

3.15

433

1482

(3016650) Hepatitis A virus Ab [Presence] in Serum

863

3499

1.56

30.42

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1300

11333

0.71

30.15

2.9

2.7

ug/l

0.7

0.85

829

6665

(3000494) Fungus identified in Specimen by Culture

4533

23787

1.22

29.89

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

384

1245

1.94

29.82

1.6

1.8

—

(3028026) IgM [Mass/volume] in Serum or Plasma

2517

12367

1.29

29.48

1.7

1.8

g/l

1.3

1.02

2315

11341

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1531

6992

1.39

29.39

4.3

4.0

mmol/l

24.9

24.7

1.91

1421

6516

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

227

3046

0.46

29.24

1.4

1.6

mmol/l

7.6

7.5

0.14

134

1854

(3020891) Body temperature

1458

6623

1.39

28.90

5.0

4.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1385

6238

1.40

28.85

2.7

2.8

g/l

3.6

3.5

0.03

1302

5925

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

773

3098

1.57

28.68

1.6

—

(3019150) Specific gravity of Urine by Refractometry

8541

47500

1.16

28.57

4.6

3.8

kg/l

1.0

0.37

1224

7325

(3025159) Blasts/100 leukocytes in Blood

3041

15355

1.26

28.56

4.2

0.2

0.11

762

3303

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

778

3139

1.56

28.05

2.8

3.4

u/ml

862.0

525.7

0.36

692

2853

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2496

19630

0.78

27.96

4.6

4.1

ug/l

1.6

2.6

4.59

2179

17679

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

379

1255

1.90

27.72

3.2

2.8

ug/l

25.2

26.0

—

(3018405) Lactate [Moles/volume] in Arterial blood

1268

5665

1.42

27.67

4.1

3.8

mmol/l

1.3

1.4

0.94

1250

5563

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2059

9938

1.31

27.50

2.4

2.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1850

8805

1.33

27.26

1.9

2.0

u/l

39.7

39.8

0.06

1645

7999

(3004588) Protein electrophoresis panel - Serum or Plasma

2234

10946

1.29

26.69

2.2

—

(40767503) Oxygen content in Capillary blood by calculation

876

3670

1.51

26.65

2.7

2.3

16.5

0.00

452

1812

(3001556) Androgen free Index in Serum or Plasma

129

271

2.99

25.84

1.7

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

692

2779

1.57

25.51

2.0

1.8

mmol/l

1.7

0.33

681

2709

(3043409) Potassium [Moles/volume] in Arterial blood

1107

4900

1.43

25.46

4.4

4.0

mmol/l

3.8

1.71

1039

4603

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1139

5071

1.42

25.36

1.7

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

1308

5965

1.39

25.35

3.0

2.9

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1370

6299

1.38

25.27

2.3

2.6

180.0

177.4

0.51

1296

5927

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

615

2407

1.61

25.25

2.3

2.6

u/ml

45.9

804.6

1.11

583

2230

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

525

1991

1.66

24.42

6.5

6.3

mg/l

11.4

11.5

0.23

473

1833

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

226

2845

0.50

24.27

1.4

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

4002

29542

0.83

24.19

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

1295

5948

1.38

24.05

1.2

1.3

titre

110.2

132.2

0.57

123

547

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1816

8784

1.31

23.87

9.5

9.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

956

4172

1.45

23.75

3.2

mmol/l

25.0

24.7

1.13

861

3661

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1079

4826

1.41

23.44

1.7

1.2

ug/l

4.3

3.3

1.04

886

4456

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

505

1917

1.66

23.42

1.0

1.1

—

(40761535) Cells panel - Urine sediment

3064

15820

1.23

23.41

3.6

3.5

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

357

1228

1.83

23.33

3.3

2.8

nmol/l

140.3

101.5

1.15

351

1203

(40768793) Breast Pathology biopsy report

1345

6254

1.36

23.14

1.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1539

7306

1.33

23.09

3.9

3.8

49.8

48.5

1.16

1516

7233

(3025941) Bacteria identified in Stool by Culture

2662

13562

1.25

23.00

1.3

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1441

6794

1.34

22.65

2.5

94.8

94.6

0.13

1322

6272

(3027273) Bicarbonate [Moles/volume] in Venous blood

1652

7946

1.32

22.62

3.6

3.3

mmol/l

25.3

0.02

1603

7696

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

231

691

2.10

22.47

2.1

2.3

nmol/l

150.2

159.3

0.61

198

608

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1145

5224

1.38

22.17

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1143

5218

1.38

22.05

1.3

—

(3021901) Oxygen saturation in Capillary blood

709

2959

1.51

22.05

2.9

2.8

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3033

15739

1.22

22.04

2.4

2.3

au/ml

24.8

22.9

0.32

140

1097

(3024980) IgG subclass 4 [Mass/volume] in Serum

812

3485

1.47

22.03

1.5

g/l

0.6

0.7

0.23

549

2697

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3661

19356

1.20

21.98

1.2

iu/ml

126.5

151.0

3.48

1318

7556

(3036489) Thrombin time

1660

8025

1.31

21.91

2.1

2.2

21.2

21.3

0.08

1410

6849

(3013139) Helicobacter pylori Ag [Presence] in Stool

3033

15754

1.22

21.83

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1610

7765

1.31

21.62

2.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1200

5551

1.37

21.36

2.0

2.1

mg/l

10.4

10.5

0.09

1100

5209

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

892

3936

1.43

20.94

3.0

2.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1473

7050

1.32

20.90

1.9

1.8

—

(3044290) Cell count panel - Cerebral spinal fluid

1006

4540

1.40

20.80

1.4

1.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

259

835

1.95

20.64

1.4

pmol/l

13.8

14.5

1.20

216

700

(3049717) Cytology report of Urine Cyto stain

1033

4691

1.39

20.60

2.3

2.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

446

1697

1.65

20.58

1.2

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

576

2334

1.55

20.53

1.2

1.3

u/l

41.1

35.6

0.26

497

2053

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1534

7405

1.31

20.48

1.7

1.8

g/l

1.5

0.58

1297

6361

(3017143) Hepatitis C virus Ab [Presence] in Serum

5307

29157

1.16

20.08

1.7

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1277

6023

1.34

20.06

2.2

1.9

ug/l

2.0

2.1

0.20

1113

5272

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2783

14459

1.22

19.95

1.3

au/ml

42.4

47.8

0.52

604

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1168

5448

1.35

19.74

1.3

1.4

mg/l

514.1

493.2

0.34

1117

5197

(3036603) Volume of Urine

336

1197

1.77

19.67

1.6

1877.0

1936.6

0.21

262

(4010399)

2762

14370

1.22

19.52

1.4

—

(3016038) Potassium [Moles/volume] in Urine

336

1200

1.76

19.51

1.5

1.4

mmol/l

35.2

34.0

0.38

288

1034

(3037121) Protein [Mass/volume] in Urine

1367

6539

1.32

19.49

3.0

3.2

g/l

0.2

0.3

3.44

560

2657

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

199

3.00

19.26

3.1

2.6

pmol/l

87.5

54.2

0.64

172

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1042

4793

1.37

19.25

1.3

1.4

mmol/l

3.7

3.6

0.45

973

4500

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

194

3.01

18.99

6.7

7.5

—

(37021550) Renin [Units/volume] in Plasma --upright

142

374

2.38

18.71

1.6

1.3

mu/l

70.1

93.2

0.48

112

288

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

168

477

2.21

18.68

1.5

1.6

ug/l

0.4

0.68

109

321

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1042

4828

1.36

18.41

1.4

1.5

e6/l

33.3

28.3

0.15

808

3725

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

364

1356

1.69

18.25

6.0

6.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1041

4834

1.36

18.14

1.5

e6/l

4625.5

1446.0

0.44

859

3905

(3017732) Neutrophils [#/volume] in Blood

2914

15352

1.20

18.08

2.9

2.6

e9/l

4.0

4.1

0.61

2204

12323

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

978

4506

1.37

17.91

1.4

1.3

—

(3024928) Oxygen saturation in Venous blood

790

3515

1.42

17.79

4.5

3.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

464

1861

1.57

17.38

3.9

3.3

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

165

3.08

17.24

3.0

1.6

nmol/l

17.7

2.3

1.67

153

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2611

13688

1.21

17.05

2.4

2.2

ug/l

5.8

6.5

1.16

2165

11809

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

940

4350

1.36

16.78

3.7

3.5

u/ml

36.4

36.9

0.03

910

4193

(3016244) Insulin [Units/volume] in Serum or Plasma

448

1799

1.57

16.72

3.1

3.3

mu/l

25.5

27.1

0.35

423

1706

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1040

4892

1.34

16.70

3.6

3.5

u/ml

0.4

0.17

591

2765

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3428

18449

1.18

16.68

1.5

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

537

2250

1.50

16.53

2.0

mg/l

26.9

24.4

0.44

161

596

(3020717) Zinc [Moles/volume] in Serum or Plasma

330

1235

1.68

16.33

1.7

1.5

umol/l

24.2

25.5

0.33

316

1181

(3010838) Calcium [Moles/time] in 24 hour Urine

281

1006

1.76

16.29

1.8

1.6

mmol/24h

6.1

5.2

0.39

(40768443) Skin Pathology biopsy report

1781

9028

1.25

16.09

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1312

6410

1.29

16.07

1.8

2.0

iu/l

10.6

13.4

0.15

485

2510

(3034860) Kappa light chains.free [Mass/volume] in Serum

1002

4717

1.34

16.02

3.4

3.2

mg/l

46.9

76.1

0.98

804

3818

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

999

4706

1.34

15.90

3.4

3.2

mg/l

36.4

46.0

0.93

797

3813

(3003327) Ova and parasites identified in Stool by Light microscopy

1690

8533

1.25

15.81

1.8

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

666

2944

1.42

15.61

1.6

—

(36660697) Celiac disease serology panel - Serum

3712

20216

1.17

15.55

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

640

2813

1.43

15.48

3.3

3.1

1.3

1.5

0.84

508

2169

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

969

4569

1.34

15.34

3.4

3.1

ratio

2.8

2.1

0.26

375

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

147

3.07

15.32

1.7

1.3

pmol/l

8.9

16.9

1.17

123

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

805

3692

1.37

15.24

1.5

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1927

9912

1.23

15.22

1.3

u/ml

1.2

0.9

0.42

181

833

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2928

15674

1.18

15.16

2.6

2.5

ml/min/173m2

70.2

69.1

0.64

1176

6120

(3030313) Adrenal Ab [Titer] in Serum

104

262

2.49

15.14

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

587

2553

1.45

15.04

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

592

2582

1.44

14.95

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

586

2560

1.44

14.68

1.5

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

1211

5928

1.29

14.65

1.2

1.3

titre

615.1

1024.4

2.01

205

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

601

2643

1.43

14.53

1.5

1.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

544

2348

1.46

14.53

2.0

1.7

89.9

90.5

1.46

534

2312

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

529

2271

1.47

14.52

4.7

4.4

u/ml

102.4

106.2

0.04

150

703

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

577

2520

1.44

14.48

3.6

3.8

u/ml

41.7

48.0

0.55

571

2491

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

584

2558

1.44

14.43

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

588

2579

1.43

14.43

1.5

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

719

3268

1.39

14.41

1.3

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

464

1943

1.50

14.40

1.7

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

950

4510

1.33

14.39

4.5

4.0

kpa

8.7

8.8

0.48

896

4215

(3000475) Leukocytes [#/volume] in Synovial fluid

919

4352

1.33

14.17

1.7

e6/l

9922.9

12124.0

1.02

666

3163

(4062490)

530

2289

1.46

14.12

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1057

5120

1.30

13.87

2.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

212

735

1.81

13.76

2.7

2.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

893

4234

1.33

13.67

1.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

526

2284

1.45

13.65

1.4

g/l

6.3

6.7

1.83

317

1653

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

248

904

1.72

13.61

2.1

2.0

umol/l

30.2

28.6

1.33

242

875

(3024139) IgG subclass 3 [Mass/volume] in Serum

525

2281

1.45

13.58

1.4

g/l

0.4

0.15

321

1651

(3028192) IgG subclass 2 [Mass/volume] in Serum

525

2282

1.45

13.55

1.4

g/l

2.8

2.9

0.64

319

1649

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1065

5181

1.30

13.55

5.3

4.8

mg/l

1.4

1.31

977

4837

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

862

4074

1.33

13.50

1.7

1.6

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

276

1040

1.67

13.43

2.1

2.0

umol/l

1.9

0.09

261

979

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1168

9220

0.79

13.41

1.9

2.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1342

6731

1.26

13.35

5.5

4.6

0.9

0.04

1260

6310

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1358

6821

1.26

13.35

5.4

4.6

1.7

0.31

1273

6390

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1336

6700

1.26

13.31

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1347

6775

1.25

13.09

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1817

9444

1.21

12.98

2.8

2.5

e6/l

0.3

0.10

1755

9083

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

954

4601

1.31

12.96

1.5

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

1348

6789

1.25

12.95

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

400

1665

1.51

12.84

1.2

1.3

mmol/l

2.0

0.31

367

1537

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

154

492

1.96

12.82

2.5

1.3

nmol/l

5.5

5.4

0.02

147

467

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2554

13711

1.18

12.77

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

542

2406

1.42

12.53

1.4

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

33840

207977

1.10

12.32

16.4

12.8

39.2

39.6

16.23

25040

160554

(40760888) Immunoglobulin light chains.free panel - Serum

752

3534

1.34

12.28

3.3

3.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

866

4155

1.31

12.25

2.3

2.1

g/l

129.6

129.5

0.01

638

3029

(3042111) Morphology [Interpretation] in Bone marrow Narrative

544

2436

1.40

11.99

1.6

1.7

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1939

10224

1.20

11.93

1.1

u/ml

1.2

11.9

1.81

157

(3006653) Thiamine [Moles/volume] in Blood

258

987

1.64

11.91

1.3

1.4

nmol/l

136.1

134.2

0.27

258

987

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1595

8258

1.22

11.88

1.4

1.5

u/ml

11.3

14.3

0.48

227

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1070

5304

1.27

11.80

2.3

g/l

0.5

0.8

2.67

895

4587

(3014271) Vancomycin [Susceptibility]

204

735

1.74

11.74

2.9

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1252

6326

1.25

11.73

1.3

u/ml

8.0

8.9

0.18

199

1018

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1357

6918

1.24

11.73

1.3

u/ml

35.4

35.8

0.02

449

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

528

2362

1.41

11.72

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1234

6228

1.25

11.68

1.3

u/ml

3.2

7.2

2.49

137

650

(3027456) Digoxin [Moles/volume] in Serum or Plasma

608

2790

1.37

11.61

3.2

nmol/l

0.8

0.24

463

2179

(46235355) HIV 1 and 2 tests - Meaningful Use set

8012

54093

0.91

11.50

2.1

1.9

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1237

6258

1.25

11.47

2.1

g/l

7.5

7.4

1.79

916

4702

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1235

6249

1.25

11.44

2.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1233

6241

1.25

11.38

2.1

g/l

3.7

3.8

0.47

871

4463

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1175

5929

1.25

11.16

2.2

g/l

3.1

0.15

889

4605

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

497

2221

1.41

11.13

1.2

u/l

60.8

62.1

0.17

344

1506

(3044927) Protein electrophoresis panel - Urine

347

1450

1.50

11.02

1.2

—

(3012565) Volume of 24 hour Urine

240

921

1.64

11.00

2.0

1987.3

1996.1

0.04

218

840

(3020961) Endomysium IgA Ab [Titer] in Serum

2346

12664

1.17

10.98

1.1

titre

122.1

221.6

1.62

329

(3042631) Mycobacterium sp identified in Specimen

458

2025

1.42

10.90

2.5

2.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

357

1510

1.49

10.71

2.6

2.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1381

7124

1.22

10.70

1.7

1.8

g/l

0.2

0.61

1317

6762

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

6712

45537

0.91

10.58

1.8

1.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

982

4886

1.27

10.55

2.1

g/l

37.7

38.1

1.34

825

4180

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1413

7323

1.22

10.46

1.7

1.8

g/l

1.2

1.79

1350

6969

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1062

5344

1.25

10.37

1.3

u/ml

38.8

43.4

0.42

122

527

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1151

5845

1.24

10.36

2.1

g/l

9.9

10.2

1.03

941

4880

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

625

2944

1.34

10.14

2.9

3.2

u/ml

19416.0

1206.6

0.51

146

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

306

1270

1.51

10.08

1.5

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.39

10.02

1.5

1.4

nmol/l

481.7

529.7

0.20

(4146454)

381

1655

1.45

10.02

2.6

2.7

—

(3045414) Leukocytes [Presence] in Urine

1840

9819

1.18

9.93

1.9

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1692

8971

1.19

9.84

1.6

1.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

832

4093

1.28

9.84

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

832

4094

1.28

9.82

1.3

—

(3000330) Specific gravity of Urine by Test strip

1800

9600

1.18

9.78

3.6

3.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1277

6611

1.22

9.59

1.6

titre

296.3

305.7

0.04

296

(3017354) Segmented neutrophils/100 leukocytes in Blood

388

1706

1.43

9.59

3.2

3.1

57.9

58.0

0.02

260

1074

(3021788) Differential panel - Synovial fluid

691

3333

1.30

9.52

1.6

1.5

—

(3045142) Bone marrow Pathology biopsy report

385

1696

1.43

9.43

1.4

1.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

263

1073

1.54

9.41

1.3

60.7

65.3

0.30

141

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

431

1939

1.40

9.38

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1041

5292

1.24

9.33

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3295

23062

0.89

9.26

1.7

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

136

1477

0.58

9.23

1.6

—

(40768800) Prostate Pathology biopsy report

1026

0.49

9.23

1.1

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1030

5238

1.24

9.20

1.5

1.4

iu/ml

20.5

14.2

0.54

139

(3000012) Reticulocyte production index

219

862

1.60

9.16

1.5

1.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

771

0.42

9.13

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

150

535

1.76

9.06

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

132

453

1.83

9.04

1.3

1.2

g/l

37.9

39.2

0.50

234

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

679

3292

1.30

9.03

1.4

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

446

2035

1.38

8.95

19.1

6.4

mmol/l

7.4

7.2

0.55

365

1662

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2526

13925

1.15

8.93

2.7

2.8

ng/l

166.9

172.5

0.25

2258

12581

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

130

446

1.83

8.92

1.2

pmol/l

343.7

357.5

0.10

338

(3010370) Gastrin [Moles/volume] in Serum or Plasma

301

2.02

8.91

2.3

1.7

pmol/l

45.6

55.1

0.33

255

(3008037) Lactate [Moles/volume] in Venous blood

726

3558

1.28

8.90

3.0

mmol/l

1.6

1.5

0.83

706

3489

(3000093) Morphology [Interpretation] in Blood Narrative

370

1637

1.42

8.88

1.2

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

2886

16061

1.14

8.85

1.3

u/ml

184.3

212.9

0.79

2669

14866

(40768441) Liver Pathology biopsy report

335

1459

1.44

8.76

1.3

1.4

—

(3023410) Appearance of Cerebral spinal fluid

492

2290

1.35

8.72

1.5

1.8

—

(3047181) Lactate [Moles/volume] in Blood

1076

5536

1.22

8.64

6.2

5.1

mmol/l

1.3

0.16

956

4900

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

116

388

1.88

8.63

1.3

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

465

2150

1.36

8.61

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

785

3906

1.26

8.53

5.2

5.7

iu/ml

596.3

1288.5

0.92

557

(40768806) Pleura Pathology biopsy report

296

1266

1.47

8.52

1.5

—

(3018133) Calcium [Moles/volume] in Urine

121

413

1.84

8.47

1.9

2.5

mmol/l

2.7

2.6

0.22

111

376

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

432

1980

1.37

8.46

2.1

32.2

32.3

0.31

427

1965

(3037756) Immunofixation for Serum or Plasma

643

3124

1.29

8.45

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

5671

38411

0.91

8.45

2.3

2.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

326

1424

1.44

8.42

1.8

2.3

100.7

99.3

0.34

301

1306

(3045424) Erythrocytes [Presence] in Urine

730

3622

1.27

8.15

1.6

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

231

953

1.52

7.95

1.6

1.8

nmol/l

1.3

0.01

176

768

(1761482) Bacteria [#/volume] in Urine by Culture

873

4435

1.24

7.94

4.6

4.1

—

(3044941) Cell count panel - Synovial fluid

584

2831

1.30

7.85

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1450

7745

1.18

7.82

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

339

1515

1.41

7.76

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

363

1642

1.39

7.75

1.4

g/l

34.8

33.0

1.65

327

1486

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

858

4366

1.24

7.70

2.3

2.1

g/l

0.0

1.48

777

3972

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

280

1212

1.45

7.64

1.1

nmol/l

10.2

4.2

0.43

222

(3020876) Protein [Mass/time] in 24 hour Urine

297

1300

1.43

7.64

2.0

g/24h

1.0

1.1

0.10

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

25781

165286

0.94

7.56

3.3

3.4

—

(3039000) Anion gap in Blood

747

3756

1.25

7.49

7.6

6.1

mmol/l

11.1

11.2

0.07

674

3374

(3018572) Chloride [Moles/volume] in Blood

747

3757

1.25

7.47

7.6

6.1

mmol/l

105.2

0.01

674

3375

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

473

2245

1.32

7.44

1.6

50.8

52.7

0.41

293

1397

(3023199) Leukocytes [#/volume] in Pleural fluid

334

1501

1.40

7.43

1.4

e6/l

2325.0

3663.7

1.15

238

1086

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

923

4753

1.22

7.42

2.3

2.1

g/l

0.0

3.07

838

4346

(1002224) Polysomnography panel

1703

9254

1.16

7.41

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

727

3649

1.25

7.40

2.5

2.3

nmol/l

0.9

0.8

1.00

602

3087

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

258

1107

1.46

7.38

1.7

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

361

1647

1.38

7.35

1.4

e6/l

89357.5

85219.1

0.04

229

1141

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

284

1244

1.43

7.30

1.3

1.5

u/l

5.9

5.7

0.15

239

1028

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

342

1549

1.39

7.28

2.3

1.9

ug/l

22.9

24.6

0.26

333

1521

(40757494) Bilirubin.total [Moles/volume] in Blood

215

893

1.51

7.22

2.1

2.3

umol/l

27.1

26.3

0.03

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

844

4319

1.23

7.22

2.3

2.1

g/l

0.0

0.00

774

3963

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

391

1813

1.35

7.20

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

972

5047

1.21

7.20

1.2

1.3

u/ml

4.7

6.0

0.24

396

(3019977) pH of Arterial blood

207

854

1.52

7.18

2.8

2.5

7.4

0.47

273

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

8349

55358

0.93

7.17

1.4

1.5

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

945

4896

1.21

7.16

1.2

u/ml

25.1

11.3

0.42

(4024509)

415

1944

1.34

7.16

1.7

1.6

—

(3038515) Glucose [Moles/volume] in Venous blood

669

3343

1.26

7.10

3.2

3.1

mmol/l

7.4

7.3

0.18

652

3284

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

418

1965

1.34

7.05

1.7

1.6

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.89

6.93

4.0

2.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

723

3657

1.24

6.91

1.2

titre

100.0

145.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

262

1144

1.44

6.88

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

381

1774

1.35

6.86

2.3

44.3

43.3

0.19

237

(3028308) Erythrocytes [#/volume] in Pleural fluid

301

1352

1.40

6.76

1.4

e6/l

63735.8

43069.9

0.47

171

785

(3026389) Candida sp identified in Specimen by Organism specific culture

719

3644

1.24

6.76

1.4

1.3

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.75

6.58

1.6

1.7

8.6

18.9

1.42

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

524

2570

1.28

6.53

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

376

1762

1.34

6.52

1.8

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

264

1168

1.42

6.49

1.3

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

408

1937

1.32

6.47

2.4

2.3

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

148

2.25

6.44

3.5

2.6

pmol/l

165.2

86.6

0.26

(3028433) Virus identified in Specimen by Culture

162

650

1.56

6.41

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

285

1283

1.39

6.36

1.3

1.2

u/l

84.2

84.7

0.04

253

1126

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

168

682

1.55

6.33

2.3

2.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

327

1.80

6.32

2.4

2.6

mg/l

19.5

46.9

1.64

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

200

845

1.49

6.26

1.6

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

469

3751

0.78

6.25

1.3

1.4

mmol/l

7.2

6.9

1.15

342

2714

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

278

1250

1.40

6.25

1.3

1.2

u/l

23.4

21.7

0.24

241

1074

(3010726) Horse dander IgE Ab [Units/volume] in Serum

658

5061

0.81

6.20

1.1

u/ml

1.4

2.3

1.13

137

1281

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

115

2.40

6.19

1.5

1.4

pmol/l

14.0

17.7

0.69

(3017509) Phencyclidine [Presence] in Urine

293

1.84

6.18

2.8

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

259

1153

1.41

6.17

1.3

1.4

—

(3042301) Urate [Moles/volume] in Synovial fluid

4.78

6.17

1.0

umol/l

363.0

314.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

202

859

1.48

6.14

1.5

—

(3001186) Copper [Moles/volume] in Serum or Plasma

141

555

1.59

6.08

1.5

1.4

umol/l

17.4

17.5

0.11

126

492

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2594

14678

1.11

6.07

2.3

2.2

u/l

5808.7

6113.4

0.18

852

6022

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1384

7523

1.16

6.07

1.8

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5146

34539

0.92

6.06

2.2

2.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

318

1471

1.36

6.04

2.5

2.6

e6/l

736.4

854.9

0.72

118

593

(3022621) pH of Urine by Test strip

2493

14081

1.12

6.03

3.1

2.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

180

751

1.50

6.01

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2269

15815

0.89

5.97

1.5

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

301

1385

1.36

5.92

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

215

1909

0.70

5.92

1.6

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

331

1549

1.34

5.84

1.5

1.3

nmol/l

1.6

1.4

1.72

296

1402

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

287

1314

1.37

5.83

1.6

1.5

u/l

6.4

6.2

0.06

138

644

(3023511) Choriogonadotropin [Units/volume] in Urine

1391

7594

1.15

5.77

1.5

1.3

—

(4094501)

919

4855

1.19

5.75

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

301

1396

1.35

5.65

1.1

—

(3045788) Cell count panel - Pleural fluid

258

1170

1.38

5.57

1.4

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

104

1054

0.62

5.56

2.9

3.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

2.57

5.52

1.7

1.6

ng/l

185.8

187.5

0.05

(3034274) Bile acid [Moles/volume] in Serum --fasting

629

4798

0.82

5.51

2.1

2.2

umol/l

6.5

6.0

0.30

466

3475

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

217

957

1.42

5.51

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

257

1168

1.38

5.49

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

477

2369

1.26

5.45

1.5

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

126

497

1.59

5.44

3.1

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

126

497

1.59

5.44

3.1

2.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1660

11716

0.88

5.43

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

194

1.97

5.42

2.1

2.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

603

3080

1.23

5.38

1.5

1.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

268

1231

1.37

5.38

1.7

127.3

132.6

0.61

250

1162

(4034850)

1243

6770

1.16

5.36

8.7

8.8

—

(3012441) Differential panel - Pleural fluid

275

1273

1.36

5.26

1.4

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

267

1234

1.36

5.17

1.2

1.3

mmol/l

6.3

6.4

0.27

240

1152

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

321

1.72

5.13

1.5

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

169

722

1.47

5.10

2.1

2.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

243

1109

1.38

5.10

1.0

1.1

94.4

95.0

0.14

191

881

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

235

1067

1.38

5.09

1.2

1.1

u/l

83.8

82.0

0.10

191

857

(3023419) Bacteria identified in Sputum by Culture

407

2005

1.27

5.02

2.6

2.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

618

3190

1.22

5.01

1.1

iu/ml

52.8

3538.4

0.66

148

783

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

197

870

1.42

5.01

1.3

1.4

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

245

1.82

4.99

2.6

3.0

u/l

817.6

2223.4

1.12

229

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

197

871

1.42

4.98

1.3

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

237

1082

1.37

4.97

1.3

u/l

509.7

405.4

0.40

221

1027

(3010503) CD19 cells [#/volume] in Blood

254

1173

1.36

4.96

2.6

e9/l

0.2

0.3

0.81

244

1146

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

199

882

1.42

4.96

1.7

138.6

150.7

1.38

184

830

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

108

2.26

4.92

1.9

1.7

65.6

55.6

0.85

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

234

1069

1.37

4.90

1.2

1.1

u/l

28.9

21.6

0.55

183

830

(3014133) Dog dander IgE Ab [Units/volume] in Serum

560

4264

0.82

4.88

1.0

1.1

u/ml

3.7

5.0

0.74

195

1688

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

339

1638

1.30

4.87

1.4

1.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.69

4.81

1.2

u/field

1.3

0.03

(3023487) Leukocytes [#/volume] in Peritoneal fluid

126

513

1.54

4.80

1.9

2.0

e6/l

4911.3

951.5

0.47

337

(3006270) Folate [Moles/volume] in Blood

351

1710

1.29

4.75

1.2

1.1

nmol/l

381.5

382.8

0.04

310

1490

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

196

874

1.41

4.75

1.1

98.9

95.4

0.53

396

(3039162) Centromere protein B Ab [Units/volume] in Serum

608

3153

1.21

4.73

1.2

1.3

u/ml

45.8

56.2

0.52

220

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

200

1.88

4.71

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

337

1635

1.29

4.71

1.1

mg/l

298.9

478.2

0.49

302

1468

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

157

674

1.46

4.67

1.3

32.8

18.9

1.16

129

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

336

1632

1.29

4.66

1.4

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

237

1.80

4.66

2.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

193

862

1.40

4.64

1.6

1.3

pmol/l

63.7

96.9

0.46

111

282

(3051611) Lipemic interference index of Serum or Plasma

408

2033

1.26

4.62

3.2

3.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

163

707

1.45

4.60

1.9

1.8

—

(3032057) Clostridioides difficile [Presence] in Stool

385

1.61

4.60

1.7

1.8

—

(3011412) CD3 cells [#/volume] in Blood

419

2096

1.26

4.59

2.4

e9/l

1.3

1.2

0.27

259

1266

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.79

4.57

1.4

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

111

445

1.56

4.55

1.2

—

(3004451) EKG impression Narrative

169

740

1.43

4.55

1.2

1.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

202

913

1.39

4.55

1.1

114.2

111.6

0.46

181

823

(3004616) Nuclear Ab [Presence] in Serum

546

2817

1.22

4.50

1.3

1.4

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

190

1.88

4.50

1.3

1.1

mg/l

57.5

41.6

1.06

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

183

815

1.41

4.49

2.1

ug/l

65.6

64.6

0.06

175

797

(3033799) Differential panel - Peritoneal fluid

109

438

1.56

4.43

2.0

1.8

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

389

1.60

4.42

1.0

ug/l

75.5

78.9

0.36

321

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

212

971

1.37

4.42

1.4

1.5

u/l

12.0

12.3

0.26

204

940

(3035947) Staphylolysin Ab [Units/volume] in Serum

201

913

1.38

4.41

1.2

1.1

iu/ml

3.7

3.5

0.15

(21494890) Protein electrophoresis panel - 24 hour Urine

301

1453

1.30

4.40

2.2

2.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

109

439

1.56

4.40

1.2

1.1

umol/24h

0.6

0.7

0.95

223

(21494434) Karyotype in Bone marrow

278

1328

1.31

4.39

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

317

1542

1.29

4.38

3.8

3.9

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

260

1231

1.33

4.37

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

318

1.66

4.35

1.2

1.1

pmol/l

17.7

3.8

0.42

(3014051) Protein [Presence] in Urine by Test strip

899

4862

1.16

4.35

2.1

2.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

244

1146

1.34

4.34

1.7

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

197

896

1.38

4.30

1.1

93.3

94.4

0.21

404

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1752

9904

1.11

4.27

1.8

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

4.07

4.24

1.3

1.4

u/field

0.6

0.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

679

3600

1.18

4.21

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

326

1.64

4.20

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

158

695

1.43

4.18

1.9

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

158

695

1.43

4.18

1.9

1.8

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

160

1399

0.72

4.17

1.2

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

164

1.91

4.16

1.2

1.3

mmol/l

5.4

5.5

0.06

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

310

1517

1.28

4.12

1.6

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

310

1517

1.28

4.12

1.6

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

310

1517

1.28

4.12

1.6

1.5

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

279

1349

1.30

4.07

1.6

1.5

ug/l

9.5

7.4

0.67

249

1212

(3023430) Cat dander IgE Ab [Units/volume] in Serum

533

3999

0.83

4.05

1.0

1.1

u/ml

3.4

5.5

2.53

193

1685

(40761995) Spermatozoa Progressive [#/volume] in Semen

375

0.47

4.02

2.7

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

374

0.47

3.99

5.4

6.4

—

(3017569) Oxygen content in Arterial blood

153

676

1.42

3.98

2.0

2.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

185

846

1.37

3.94

1.1

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

124

2.02

3.91

1.3

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

378

1910

1.24

3.87

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.79

3.84

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

822

5927

0.87

3.84

1.1

u/ml

1.9

1.7

0.10

300

2435

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

118

501

1.48

3.79

1.4

1.2

—

(3022229) Phosphate [Moles/volume] in Urine

161

1.87

3.78

1.9

2.9

mmol/l

20.5

20.3

0.02

143

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

290

1426

1.28

3.75

1.3

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

126

544

1.45

3.73

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

458

3454

0.83

3.72

1.0

1.1

u/ml

0.1

0.5

3.21

730

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

114

2.03

3.69

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

106

444

1.50

3.65

1.6

1.9

u/l

38.5

30.0

0.21

399

(3044007) Cell count panel - Peritoneal fluid

409

1.52

3.64

2.0

1.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

197

923

1.34

3.63

1.1

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

125

542

1.45

3.63

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.77

3.62

1.2

1.1

mmol/l

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

306

1.60

3.59

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

346

1.56

3.57

1.3

g/l

15.1

13.0

1.08

258

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

280

0.42

3.56

1.1

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

429

2219

1.21

3.55

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1094

6095

1.13

3.51

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

109

464

1.47

3.49

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

510

2686

1.19

3.49

1.7

1.6

titre

1593.3

2622.5

0.47

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

348

1.55

3.49

5.8

4.3

u/l

53.7

57.9

0.10

132

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

180

838

1.35

3.48

1.2

1.3

u/l

12.0

12.3

0.11

164

768

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

203

1.73

3.47

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

793

4330

1.15

3.46

3.9

3.2

mg/l

22.8

24.9

0.85

487

2640

(3043410) Blood group antigens tested for on Red Blood Cells

120

522

1.44

3.45

1.7

1.6

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

2.75

3.41

2.7

2.0

umol/l

1679.8

1702.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

145

1242

0.73

3.41

1.2

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

541

3986

0.85

3.40

1.2

1.3

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

105

2.03

3.40

1.1

1.0

u/ml

0.1

0.87

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

108

462

1.47

3.39

1.8

e6/l

15799.7

9175.5

0.31

234

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

574

3063

1.18

3.39

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

262

1.63

3.38

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

742

5334

0.87

3.37

1.1

u/ml

4.0

5.5

2.16

345

2802

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1288

7267

1.11

3.34

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

277

1377

1.26

3.33

1.1

u/l

1.0

0.04

127

589

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

273

1355

1.26

3.32

1.8

1.9

mg/l

3.7

3.6

0.11

254

1299

(3047189) Immunofixation for 24 hour Urine

136

610

1.40

3.32

2.1

1.9

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

181

851

1.33

3.30

1.2

112.8

110.9

0.48

169

752

(4306422)

670

3628

1.16

3.30

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

316

1597

1.24

3.30

2.3

2.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

337

1716

1.23

3.28

2.2

73.7

73.5

0.06

325

1659

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.05

3.28

1.1

u/l

52.1

63.4

0.32

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

195

1591

0.77

3.27

1.3

1.4

mmol/l

5.6

5.4

1.86

184

1504

(3016228) CD19 cells/100 cells in Blood

169

788

1.35

3.26

2.1

8.8

8.7

0.04

163

770

(3008401) Mugwort IgE Ab [Units/volume] in Serum

706

5078

0.87

3.25

1.1

u/ml

1.3

1.0

0.49

274

2199

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

394

2043

1.21

3.22

1.1

1.2

mg/l

35.6

39.6

1.01

316

1700

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1311

7423

1.11

3.20

1.1

u/ml

3.5

5.4

1.54

163

1016

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

340

1738

1.23

3.20

1.2

u/ml

73.7

65.9

0.17

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

296

1.57

3.19

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

301

1.56

3.19

1.4

g/l

29.7

26.2

0.92

219

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

198

949

1.31

3.18

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

217

1054

1.29

3.16

2.7

2.8

42.4

41.9

0.14

379

(21494814) CD8 cells/100 lymphocytes in Specimen

165

771

1.34

3.16

2.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

332

1.53

3.14

2.2

2.3

mmol/l

6.9

7.4

0.54

194

(3025577) Chromium [Mass/volume] in Blood

177

837

1.33

3.13

2.0

2.1

ug/l

2.4

2.7

0.33

146

712

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

132

596

1.39

3.13

2.1

2.0

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

340

1743

1.22

3.13

1.2

u/ml

30.7

47.3

0.97

134

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

156

724

1.35

3.12

2.7

2.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1661

9530

1.10

3.12

1.7

1.6

mg/l

3.5

3.4

0.08

1215

6601

(44806118)

403

2102

1.20

3.11

1.6

1.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

211

1024

1.29

3.10

1.0

ng/l

493.9

324.2

0.52

161

733

(44790048)

403

2103

1.20

3.10

1.6

1.5

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.07

3.06

1.1

1.0

u/ml

0.0

0.1

—

(3045716) Anion gap in Serum or Plasma

159

743

1.34

3.06

2.8

2.5

mmol/l

9.5

9.1

0.59

118

553

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.13

3.04

1.0

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

120

536

1.40

3.04

1.1

90.7

87.5

0.19

112

(44790049)

402

2102

1.20

3.04

1.6

1.5

—

(44790047)

402

2103

1.20

3.02

1.6

1.5

—

(3038026) Centromere Ab [Units/volume] in Serum

347

1790

1.22

3.02

1.2

1.3

u/ml

54.2

50.7

0.06

(3035320) C reactive protein [Mass/volume] in Body fluid

314

1604

1.23

3.01

2.5

2.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.48

3.00

1.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

117

522

1.41

2.99

1.2

1.3

nmol/l

116.2

121.4

0.15

383

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

120

538

1.40

2.98

1.1

—

(40762814) Titanium [Mass/volume] in Blood

237

1.61

2.98

2.4

2.3

ug/l

3.1

4.3

1.31

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

308

1572

1.23

2.98

1.1

ratio

1.1

1.32

101

574

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

233

1152

1.27

2.98

1.2

1.3

titre

551.5

435.4

0.11

(43055442) Apixaban [Mass/volume] in Serum or Plasma

189

1.69

2.98

1.6

1.4

ug/l

95.7

120.5

0.80

160

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

114

507

1.41

2.97

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

211

1031

1.28

2.96

1.0

ng/l

791.8

737.9

1.06

157

712

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

368

1914

1.21

2.95

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

304

1554

1.23

2.91

1.4

umol/l

10.9

11.3

0.44

285

1489

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

103

1.95

2.91

1.1

1.0

u/field

1.2

0.06

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

338

1747

1.21

2.90

1.2

titre

163.8

191.1

0.27

319

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

211

1036

1.28

2.87

1.0

ng/l

38.9

42.6

0.60

160

725

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

118

532

1.39

2.86

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

328

1694

1.22

2.85

2.2

12.0

13.1

1.01

162

897

(3004716) Salmonella sp identified in Stool by Organism specific culture

2374

13884

1.08

2.84

1.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

226

1121

1.26

2.83

1.2

1.3

titre

60.0

57.7

0.04

105

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

191

928

1.29

2.82

1.8

1.7

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

336

1742

1.21

2.81

1.2

titre

270.0

207.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

132

1.80

2.77

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

225

1119

1.26

2.77

1.3

1.2

u/l

264.3

293.2

0.22

208

1051

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

378

1985

1.20

2.77

1.1

mg/l

231.1

233.5

0.10

324

1736

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

190

926

1.29

2.75

1.8

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

190

926

1.29

2.75

1.8

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

190

926

1.29

2.75

1.8

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1176

6681

1.11

2.75

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

587

3197

1.15

2.75

1.8

titre

1.2

6.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

118

537

1.38

2.72

1.1

68.8

73.9

0.26

109

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4302

28288

0.95

2.72

1.7

1.9

—

(3025315) Body weight

133

1.79

2.72

4.3

3.6

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

322

1670

1.21

2.70

1.2

u/ml

5.5

10.9

0.88

140

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

190

929

1.28

2.69

1.2

g/l

0.3

1.84

157

728

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

299

1.51

2.69

1.2

1.4

ng/l

43.2

62.7

0.75

177

(3037692) Legionella sp identified in Specimen by Organism specific culture

123

565

1.37

2.69

1.5

1.4

—

(3051651) Icteric interference index of Serum or Plasma

237

1191

1.25

2.68

3.5

—

(3035880) pH of Pleural fluid

140

657

1.34

2.67

1.2

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

134

1.78

2.66

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

178

865

1.29

2.65

2.0

ug/l

3.2

3.9

0.71

157

762

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

688

3799

1.14

2.65

2.4

ug/min

85.7

87.3

0.03

388

2284

(1761868) Lipid panel - Serum or Plasma

13246

81059

1.04

2.63

2.8

2.5

—

(3024263) Appearance of Synovial fluid

187

919

1.28

2.57

1.8

—

(3023383) Lactate [Moles/volume] in Pleural fluid

364

1.45

2.57

1.3

mmol/l

3.5

3.3

0.19

336

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

170

826

1.29

2.55

1.3

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

170

826

1.29

2.55

1.3

1.7

—

(3026726) Creatinine [Moles/volume] in Specimen

113

1.83

2.54

1.4

2.5

umol/l

526.7

390.3

0.23

108

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

213

1.59

2.54

1.2

1.3

nmol/l

17.5

15.6

0.27

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

263

1.53

2.53

1.2

1.1

—

(3036005) Urine sediment comments by Light microscopy Narrative

3.30

2.53

1.0

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

184

906

1.27

2.50

2.6

2.5

umol/l

55.4

52.2

0.65

146

760

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

303

1576

1.21

2.50

2.5

e6/l

509.6

537.6

0.35

253

1303

(4027681)

310

1617

1.20

2.48

1.3

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

165

802

1.29

2.48

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

210

1.58

2.46

3.3

2.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

658

3646

1.13

2.44

1.3

1.2

u/ml

5.2

3.8

1.14

274

1600

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

632

3493

1.14

2.43

1.1

121.6

120.3

0.44

568

3157

(3051593) INR in Capillary blood by Coagulation assay

138

657

1.32

2.42

8.5

10.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

143

1.71

2.42

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

267

1.50

2.38

1.2

1.3

—

(4015189)

412

1.40

2.38

2.3

2.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

505

2754

1.15

2.38

1.1

g/l

1.5

0.21

457

2493

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

164

802

1.28

2.37

4.1

2.9

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

107

1.82

2.35

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

273

1.49

2.35

1.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

103

472

1.37

2.33

1.9

2.0

ug/l

2.6

3.8

0.51

305

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

218

1.55

2.33

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

130

618

1.32

2.32

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

403

2935

0.86

2.32

2.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

177

877

1.27

2.31

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

100

458

1.37

2.28

1.3

44.5

40.5

0.43

310

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

225

1.53

2.25

1.1

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

220

1.54

2.25

1.7

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

682

4781

0.89

2.22

1.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

282

1.47

2.21

1.3

1.2

ug/l

617.2

251.8

0.46

165

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.00

2.20

1.0

1.1

pmol/l

205.1

221.2

0.07

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

292

1536

1.19

2.18

2.6

e9/l

0.2

0.22

254

1303

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

8338

53760

0.96

2.17

1.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

315

1.43

2.15

1.5

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

2.76

2.14

1.3

1.5

umol/l

2890.0

3230.6

0.08

(40768795) Lymph node Pathology biopsy report

376

2025

1.17

2.13

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

161

1262

0.80

2.09

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

338

1.41

2.09

1.8

2.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

136

662

1.29

2.08

1.7

1.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

391

1.38

2.08

1.5

1.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

170

1.59

2.06

2.4

3.4

—

(3006598) pH of Arterial cord blood

149

0.42

2.06

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

356

1918

1.16

2.03

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

172

865

1.25

2.03

6.6

5.2

u/ml

2274.4

5399.8

0.31

145

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

448

2455

1.15

2.03

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

368

1988

1.16

2.03

1.1

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

293

1.43

2.03

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

364

1965

1.16

2.02

1.1

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

196

1.54

2.02

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

242

1.48

2.00

1.2

mmol/l

2.1

1.8

0.41

150

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

132

644

1.29

2.00

1.6

1.9

u/ml

2695.7

43445.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

421

1.36

2.00

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

364

1968

1.16

1.99

1.1

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

852

4855

1.10

1.99

1.6

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

363

1963

1.16

1.98

1.1

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

380

1.37

1.95

1.3

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

366

1985

1.16

1.93

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

366

1986

1.16

1.92

1.1

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

262

1384

1.19

1.92

1.7

1.4

umol/l

55.4

68.0

2.89

115

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

293

1.41

1.87

3.5

2.5

mmol/l

0.8

1.5

1.78

219

(3032868) Hemoglobin electrophoresis panel in Blood

200

1.50

1.86

1.5

1.6

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

116

1.68

1.86

3.2

2.3

—

(3022475) Manganese [Moles/volume] in Blood

160

1.57

1.86

1.3

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

232

0.57

1.82

6.1

7.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

177

1.52

1.78

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.26

1.77

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

248

1315

1.18

1.77

1.4

1.5

u/ml

19.3

22.9

0.67

245

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

176

1338

0.82

1.76

1.7

1.8

—

(3023420) DNA double strand Ab [Units/volume] in Serum

475

2642

1.13

1.76

1.5

1.6

iu/ml

35.7

34.0

0.06

122

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

115

915

0.79

1.76

1.0

1.1

u/ml

9.3

9.7

0.04

117

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.92

1.75

1.0

1.1

u/field

0.7

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

147

741

1.24

1.75

1.2

g/l

0.2

0.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

124

613

1.27

1.74

3.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

320

1735

1.16

1.74

1.5

41.7

34.1

2.50

192

1056

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

103

828

0.78

1.72

1.1

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.95

1.72

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

199

1.48

1.72

1.6

1.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.09

1.71

3.5

3.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

146

738

1.24

1.70

2.8

2.9

umol/l

28.3

28.6

0.09

113

550

(3000285) Sodium [Moles/volume] in Blood

220

1.45

1.70

1.3

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

232

1228

1.18

1.70

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

262

1.41

1.69

1.8

1.9

—

(3048879) Bone marrow aspiration report

413

1.32

1.67

1.7

1.9

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

3.42

1.67

1.0

1.1

nmol/24h

24.6

28.4

—

(4211845)

220

1163

1.19

1.65

3.7

2.8

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

576

3996

0.90

1.64

2.7

2.4

13.3

13.1

3.31

571

3944

(3028717) Thiamine [Mass/volume] in Blood

222

1.44

1.64

1.3

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

331

0.66

1.62

18.3

7.8

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

121

1.61

1.62

1.4

1.5

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

3.92

1.61

2.0

9.1

—

(4212803)

131

1.58

1.61

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

167

864

1.21

1.59

26.8

27.6

ug/l

116.9

123.0

0.47

136

723

(3006576) Bicarbonate [Moles/volume] in Blood

105

516

1.28

1.58

5.5

5.9

mmol/l

24.8

25.0

0.23

477

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

440

1.30

1.55

1.4

61.4

62.0

0.06

366

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

231

1234

1.17

1.55

1.1

1.2

u/ml

16.8

12.6

0.16

131

(3003129) Base excess in Capillary blood by calculation

380

1.32

1.55

1.6

1.7

mmol/l

0.6

0.9

0.25

362

(3007916) DNA double strand Ab [Titer] in Serum

299

1.36

1.55

1.3

1.4

titre

245.7

100.3

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

204

1.44

1.55

1.0

1.1

u/ml

7.5

3.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

340

2421

0.88

1.54

1.4

mmol/l

12.7

11.1

1.58

436

(3029075) Extractable nuclear Ab panel - Serum

145

742

1.23

1.54

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

113

1.61

1.54

2.2

2.6

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

153

1.52

1.53

2.2

1.4

46.3

35.8

0.75

104

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

273

1.38

1.53

1.8

1.3

40.3

56.1

1.68

139

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.56

1.51

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

381

2688

0.89

1.50

1.2

1.3

—

(3008898) HLA-B27 [Presence]

1611

9535

1.06

1.50

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

285

2045

0.87

1.47

1.3

1.4

nmol/l

31.9

31.2

0.12

256

1877

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

525

2974

1.11

1.47

1.2

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

461

1.28

1.46

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

232

0.62

1.46

1.1

1.4

mmol/l

5.9

7.6

—

(3013762) Body weight Measured

1.82

1.45

1.0

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

145

1.51

1.45

1.2

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

658

3777

1.09

1.42

1.3

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

177

1.45

1.41

1.2

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

151

785

1.21

1.41

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

130

666

1.22

1.40

1.1

—

(4268621)

444

2501

1.11

1.40

2.4

2.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

688

3961

1.09

1.39

1.1

u/ml

3.3

2.8

0.47

307

1977

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

229

0.63

1.39

1.1

1.2

mmol/l

22.1

20.3

1.17

184

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

252

1.37

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.69

1.35

2.0

2.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

373

1.29

1.34

1.4

2.3

2.6

0.13

314

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

145

756

1.20

1.33

1.4

1.2

—

(3006462) Nitrate [Presence] in Urine

199

1067

1.17

1.33

3.8

2.8

—

(3026250) Tacrolimus [Mass/volume] in Blood

168

889

1.18

1.31

39.5

36.7

ug/l

7.2

0.23

152

822

(3037556) Urate [Mass/volume] in Serum or Plasma

463

1.26

1.31

1.2

1.3

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

196

1.41

1.30

2.0

3.0

7.7

8.9

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

139

1.49

1.30

1.1

u/l

20.0

25.6

1.02

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

651

3756

1.09

1.28

1.1

—

(3002619) Bacteria identified in Specimen by Culture

409

1.27

1.28

1.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.16

1.26

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.16

1.26

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.16

1.26

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.16

1.26

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.16

1.26

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.16

1.26

2.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

278

1.33

1.26

2.4

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

135

1.49

1.25

2.4

1.4

18.4

11.1

0.69

101

(3041672) Baker's yeast Ab [Presence] in Serum

161

0.58

1.25

1.0

1.1

—

(3004775) Volume in Urine collected for unspecified duration

222

1209

1.15

1.23

2.2

2.3

675.6

629.4

0.81

152

872

(44806071)

312

1.31

1.23

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

300

1669

1.13

1.21

2.6

2.9

mg/l

39.9

52.9

0.47

209

1172

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

134

701

1.20

1.21

4.0

4.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.03

1.21

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

104

795

0.82

1.20

1.1

—

(44813793)

346

1943

1.12

1.20

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

319

1.30

1.19

1.5

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

168

1.42

1.19

1.2

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

142

1.46

1.19

1.9

1.8

umol/l

46.7

47.4

0.04

142

(3022493) Free Hemoglobin [Mass/volume] in Plasma

149

789

1.18

3.7

4.1

mg/l

1341.3

2215.7

0.26

105

578

(3003338) MCHC [Mass/volume]

30912

194829

0.98

1.17

19.7

15.1

g/l

331.0

332.0

70.00

30696

193327

(3013862) HLA-DP [Type]

1.65

1.16

1.1

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

262

1451

1.13

1.15

1.1

1.2

—

(3003694) ABO and Rh group [Type] in Blood

10448

66548

0.98

1.13

1.5

1.6

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

113

1.50

1.12

2.0

1.3

0.4

1.8

2.24

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

654

3804

1.08

1.10

1.2

u/ml

3.2

3.6

0.24

189

1294

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

492

1.22

1.09

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

492

1.22

1.09

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

492

1.22

1.09

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

492

1.22

1.09

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

291

1.29

1.08

5.4

5.0

ug/min

50.3

33.9

1.00

209

(3011436) Histone Ab [Units/volume] in Serum

487

1.22

1.08

1.1

u/ml

—

26.8

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

367

0.75

1.08

18.4

7.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

824

4838

1.07

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2419

15726

0.96

1.07

1.7

—

(3049233) Organic acids panel - Urine

1.81

1.07

1.0

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

226

1.33

1.07

11.6

10.2

mmol/l

4.8

5.2

0.67

226

(3015076) Soybean IgE Ab [Units/volume] in Serum

232

1643

0.88

1.07

1.0

1.1

u/ml

0.4

0.8

0.63

236

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

296

1662

1.12

1.06

1.1

—

(3020650) Glucose [Presence] in Urine

116

609

1.19

1.05

1.5

—

(3022670) pH of Venous cord blood

0.45

1.04

1.0

—

(3016031) Almond IgE Ab [Units/volume] in Serum

242

0.70

1.04

1.0

u/ml

0.1

0.8

—

148

(3038177) Helicobacter pylori Ab [Presence] in Serum

715

4188

1.07

1.02

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

139

744

1.17

1.01

2.1

ug/min

49.3

103.1

0.69

148

(3040794) Aluminum [Moles/volume] in Urine

0.00

1.00

0.0

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

175

1.36

0.99

2.2

3.2

mg/l

1.5

1.3

0.13

121

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.52

0.98

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

286

1612

1.11

0.98

2.1

u/field

2.5

0.07

137

701

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

224

1.32

0.98

1.2

1.1

umol/24h

1.5

1.6

0.62

224

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

138

1.41

0.98

1.1

1.2

25.8

22.8

—

(40763590) HLA-DQ beta [Type]

1.59

0.97

1.1

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.59

0.97

1.1

1.0

—

(40760409) HLA-A [Type] by High resolution

1.59

0.97

1.1

1.0

—

(40760410) HLA-B [Type] by High resolution

1.59

0.97

1.1

1.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

789

4650

1.06

0.95

1.4

u/ml

12.5

21.2

2.08

(3016750) Collection duration of Urine

172

942

1.14

0.95

2.2

min

501.6

504.0

0.11

129

731

(1617658) Protocol used for examination of sentinel lymph nodes

367

2100

1.10

0.95

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

143

773

1.16

0.94

2.2

2.3

e6/l

467.4

222.1

0.53

440

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

174

955

1.14

0.93

1.3

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

795

4690

1.06

0.93

1.5

1.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.81

0.92

1.3

1.1

1.8

2.3

0.53

(3020356) Listeria sp identified in Specimen by Organism specific culture

210

1.31

0.92

1.2

1.1

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.53

0.91

1.0

1.4

—

12425.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

430

1.21

0.90

1.2

1.3

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

1.70

0.90

1.6

1.4

nmol/l

167.9

131.3

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

1.66

0.89

3.9

2.3

umol/l

42.7

34.8

0.57

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

341

0.77

0.89

1.0

1.1

u/ml

0.3

3.4

3.08

265

(3022689) Creatine [Moles/volume] in Urine

103

547

1.18

0.86

1.3

1.5

—

(3017704) Immunofixation for Urine

154

844

1.14

0.86

1.5

1.6

—

(4133840)

547

0.82

0.86

1.1

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

126

1.39

0.85

1.3

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

158

869

1.14

0.85

1.2

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

136

0.64

0.84

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

289

1987

0.91

0.83

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

218

1226

1.11

0.82

1.1

u/ml

8.3

11.3

0.65

214

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

293

1.24

0.81

1.4

22.0

24.4

0.27

247

(3006245) CD3-CD19+ cells/100 cells in Blood

178

991

1.13

0.80

2.3

2.4

11.3

10.6

0.29

169

934

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

117

1.39

0.80

1.2

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

186

0.71

0.80

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

166

921

1.13

0.79

1.5

3.0

4.2

0.47

211

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

346

1.21

0.78

2.2

2.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

513

0.83

0.78

1.2

1.1

—

(40760512) CD34 cells/100 cells in Bone marrow

2.24

0.77

1.2

1.7

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

156

1.33

0.77

1.5

1.3

ml/s/173m2

1.4

1.9

0.44

103

(3004446) Plasmodium sp identified in Blood by Light microscopy

277

0.77

2.3

2.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

491

1.17

0.76

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1303

8497

0.96

0.75

1.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.66

0.74

1.3

4.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

157

874

1.13

0.73

1.1

ng/l

518.3

499.9

0.02

194

(3045683) HLA typing for celiac disease panel - Blood or Tissue

290

1668

1.09

0.73

1.0

—

(3034426) Prothrombin time (PT)

144

798

1.13

0.72

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

270

1.23

0.71

1.1

—

(3000492) Spirometry study

3461

21195

1.03

0.71

1.4

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

103

559

1.16

0.70

1.4

40.8

51.5

1.98

478

(3042010) Triglyceride [Moles/volume] in Pleural fluid

203

1.27

0.70

1.2

mmol/l

2.0

1.6

0.12

134

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

769

4582

1.05

0.70

1.3

u/ml

266.6

261.3

0.22

499

2933

(3046861) Legionella sp Ag [Presence] in Urine

1.43

0.70

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1632

9886

1.04

0.70

1.3

miu/ml

210.5

225.1

0.90

676

4940

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.64

0.70

2.0

1.3

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

1.64

0.70

6.4

7.5

34.8

48.6

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

107

583

1.15

0.70

1.1

mg/g

6.3

5.7

0.47

555

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

148

1.31

0.69

1.1

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

266

1.23

0.68

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1865

11331

1.03

0.68

1.4

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

462

1.17

0.68

1.1

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

729

4345

1.05

0.67

1.5

1.4

u/ml

124.0

108.8

1.20

158

962

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

169

952

1.11

0.66

2.2

2.3

27.0

28.2

0.64

164

912

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

112

615

1.14

0.66

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

111

1.36

0.66

1.0

1.1

—

(36303858) Crystals [Presence] in Urine

1.62

0.66

1.1

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

273

1854

0.92

0.65

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

117

1.34

0.64

3.4

4.8

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

244

1405

1.09

0.63

1.3

g/l

1.5

0.10

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

205

0.76

0.62

1.0

1.1

u/ml

3.7

9.2

2.18

144

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.49

0.62

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.42

0.61

10.9

7.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

692

4133

1.05

0.61

1.1

au/ml

16.6

10.8

0.68

270

(3003577) Lead [Moles/volume] in Blood

140

0.72

0.61

1.3

1.4

umol/l

0.2

—

(40757373) Influenza virus identified in Isolate

351

1.18

0.60

1.7

1.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

174

1.26

0.60

1.1

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

105

579

1.14

0.60

1.1

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.43

0.60

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

410

0.84

0.60

2.1

2.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

254

1.21

0.59

1.2

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.39

0.59

1.0

1.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

196

0.77

0.59

1.0

u/ml

7.1

16.7

1.95

161

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.52

0.58

1.1

—

(3020491) Glucose [Moles/volume] in Blood

242

1641

0.92

0.58

1.9

1.7

mmol/l

6.5

6.3

0.50

167

1236

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

114

1.32

0.58

1.3

ug/l

110.6

103.0

0.07

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

359

1.17

0.57

6.2

6.3

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.34

0.56

1.1

mg/l

0.0

0.05

(3044009) aPTT.lupus sensitive (LA screen)

227

1.21

0.56

1.2

—

(3017400) Magnesium [Moles/volume] in Urine

1.50

0.56

1.0

1.4

mmol/l

2.1

3.1

1.34

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.63

0.56

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

655

4295

0.95

0.55

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

160

1.25

0.54

1.3

1.4

71.0

72.9

0.12

137

(3032352) Blasts [#/volume] in Cerebral spinal fluid

217

1.21

0.54

1.6

3.0

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

200

1.22

0.53

5.3

4.5

mg/l

2.2

2.4

0.14

169

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

166

1.25

0.53

1.2

1.3

u/l

34.0

247.4

0.64

123

(3019174) dRVVT (LA screen)

223

1.21

0.53

1.1

1.2

—

(3049242) von Willebrand panel - Platelet poor plasma

1.39

0.53

1.8

1.5

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.59

0.53

1.0

u/ml

3.4

13.0

—

(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay

1.45

0.53

1.2

66.7

62.2

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

129

0.73

0.53

1.5

1.3

mg/l

1.4

1.6

—

110

(3002523) Influenza virus A Ag [Presence] in Specimen

655

4290

0.96

0.53

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

105

737

0.89

0.52

2.9

1.7

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.34

0.50

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.34

0.50

1.1

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.57

0.49

1.0

1.5

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

231

1.19

0.49

3.3

umol/l

37.8

41.5

0.58

197

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

100

560

1.12

0.49

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

127

877

0.91

0.48

1.7

2.0

mg/l

8.9

9.5

0.61

101

708

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

441

2625

1.05

0.48

1.1

iu/ml

1.6

2.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

533

3496

0.95

0.48

1.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.47

0.47

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

486

0.88

0.47

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

486

0.88

0.47

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

486

0.88

0.47

1.0

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1166

7091

1.03

0.46

1.6

iu/ml

2.0

6.3

0.61

236

1427

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

233

1.18

0.46

1.6

1.7

mg/l

3.6

4.1

0.18

154

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

233

1.18

0.46

1.6

1.7

mg/l

1.7

1.0

0.33

156

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

233

1.18

0.46

1.6

1.7

mg/l

4.0

2.7

0.48

163

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

233

1.18

0.46

1.6

1.7

mg/l

1.2

2.6

1.74

157

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

233

1.18

0.46

1.6

1.7

mg/l

3.5

2.0

0.67

172

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

233

1.18

0.46

1.6

1.7

mg/l

3.4

2.9

0.17

164

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

233

1.18

0.46

1.6

1.7

mg/l

2.1

1.8

0.16

143

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

233

1.18

0.46

1.6

1.7

mg/l

1.9

1.7

0.10

165

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

233

1.18

0.46

1.6

1.7

mg/l

0.7

1.1

0.43

148

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

301

1777

1.06

0.45

1.1

iu/ml

7.5

8.1

0.17

430

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

119

1.26

0.45

1.1

u/l

2.8

3.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.42

0.45

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

125

1.25

0.44

2.1

1.4

umol/24h

413.0

300.9

1.67

125

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.29

0.44

1.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

240

1.18

0.44

1.6

1.7

mg/l

1.5

1.8

0.20

160

(3045759) Histamine [Moles/volume] in Serum or Plasma

1.65

0.44

1.2

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

387

1.13

0.43

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

548

0.89

0.43

1.1

1.3

u/ml

7.3

8.0

0.05

122

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

429

1.12

0.43

1.2

mg/l

0.7

64.9

2.51

310

(3011841) English Walnut IgE Ab [Units/volume] in Serum

335

0.86

0.42

1.0

1.1

u/ml

0.0

5.2

2.61

258

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

109

1.26

0.42

3.0

5.1

—

(3042733) HLA Ab [Presence] in Serum

112

638

1.10

0.42

5.0

4.8

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

178

1.20

0.41

1.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

1.49

0.41

2.6

2.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

155

899

1.08

0.40

1.1

u/ml

64.0

9.5

0.42

537

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

424

2539

1.05

0.40

1.1

93.1

94.6

0.56

396

2380

(3033942) Copper [Moles/time] in 24 hour Urine

110

1.25

0.40

1.5

1.2

umol/24h

1.7

0.6

0.61

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.41

0.40

7.0

7.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

272

1.15

0.40

1.3

1.2

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

225

0.84

0.39

1.0

u/ml

0.2

1.9

1.99

145

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.36

0.39

1.2

nmol/l

286.1

273.9

0.06

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.27

0.39

1.2

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

136

922

0.92

0.38

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

190

0.82

0.38

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

321

1.13

0.37

1.5

nmol/l

266675.9

308599.9

0.07

256

(3045462) Protein/Creatinine [Ratio] in Urine

274

1.14

0.37

4.9

6.0

g/mol

34.3

236.4

0.62

253

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

197

1315

0.94

0.37

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

138

933

0.93

0.37

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

191

1122

1.07

0.37

2.0

1.7

u/field

1.8

2.3

0.79

142

796

(3009871) Measles virus Ab [Titer] in Serum

125

848

0.92

0.36

1.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

559

3632

0.96

0.36

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.39

0.35

1.0

titre

1598.3

1822.6

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

565

0.91

0.34

1.1

u/ml

1.2

7.9

2.38

404

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.67

0.34

2.3

2.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

119

0.79

0.34

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

160

0.82

0.34

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

130

876

0.93

0.33

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

274

1803

0.95

0.33

1.0

1.1

u/ml

10.6

5.1

0.25

483

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

462

1.10

0.33

1.3

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

326

0.88

0.32

1.2

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

409

1.10

0.32

1.2

1.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

232

0.86

0.31

1.0

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

398

1.10

0.31

1.1

u/ml

0.4

0.2

0.25

238

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.23

0.29

1.6

u/l

0.0

0.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.23

0.29

2.8

3.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

105

708

0.93

0.29

1.6

1.7

au/ml

161.0

149.3

0.06

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.24

0.28

1.0

u/ml

0.1

0.16

(3019768) Coxiella burnetii Ab [Presence] in Serum

122

0.82

0.27

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

193

1.14

0.26

1.3

1.4

10.7

10.3

0.03

104

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2975

18858

0.99

0.26

1.8

—

(40768446) Kidney Pathology biopsy report

128

755

1.06

0.25

2.0

1.7

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

309

1865

1.04

0.25

1.3

u/ml

0.5

1.1

1.83

141

749

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.20

0.25

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.31

0.25

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

129

1.17

0.25

1.1

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

248

1.11

0.24

2.8

2.3

u/field

0.6

0.8

1.30

248

(40765096) Chromosome analysis panel by Banding

441

1.08

0.24

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

305

0.90

0.23

1.1

1.0

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

317

0.91

0.22

1.0

1.1

u/ml

0.1

0.9

1.38

174

(3016072) Theophylline [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

270

1632

1.04

0.22

1.3

1.2

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.22

0.0

1.3

—

(3012787) Ethosuximide [Moles/volume] in Serum or Plasma

0.00

0.22

0.0

3.8

—

355.1

—

(3052592) Norovirus Ag [Presence] in Stool

383

1.08

0.21

1.6

1.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.81

0.21

1.0

1.2

—

(3024316) Viscosity of Plasma

1.19

0.21

1.1

1.5

mpas

1.3

1.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

108

1.16

0.20

1.7

1.8

—

(40758358) Immune stain study

114

1.15

0.20

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.21

0.20

1.0

mmol/24h

131.2

137.9

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

134

881

0.95

0.20

1.2

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.25

0.19

1.0

1.1

ng/l

1411.6

6192.7

—

(3009677) Dengue virus Ab [Presence] in Serum

104

0.84

0.19

1.0

1.1

—

(4038314)

0.84

0.19

1.4

1.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

196

0.90

0.19

1.2

1.1

u/ml

0.8

1.4

0.44

135

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

287

0.92

0.18

1.0

1.1

u/ml

0.7

0.5

0.11

155

(3014891) Appearance of Pleural fluid

181

1.11

0.18

1.5

1.6

—

(3032641) Amino acids panel - Urine

1.15

0.18

1.7

1.3

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.19

0.18

1.1

1.0

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

103

0.85

0.18

1.0

u/ml

0.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

273

0.92

0.17

5.9

5.6

72.2

68.7

0.35

207

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.12

0.17

1.0

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.21

0.16

1.1

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.78

0.16

1.3

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.78

0.16

1.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

336

0.93

0.16

1.0

u/ml

0.1

0.2

0.97

199

(3018001) Oat IgE Ab [Units/volume] in Serum

200

0.91

0.16

1.1

1.0

u/ml

0.1

1.1

0.62

(3032743) Legionella sp IgG Ab [Presence] in Serum

123

1.12

0.15

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

192

1166

1.03

0.15

1.1

miu/ml

1634.8

1469.8

1.02

192

1166

(3002621) Streptococcal DNAse B [Units/volume] in Serum

232

1.08

0.15

1.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.15

0.13

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.15

0.13

2.2

1.3

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

0.84

0.13

1.0

—

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

125

1.10

0.12

1.5

1.2

—

(3015183) Erythrocyte sedimentation rate

219

1339

1.03

0.12

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

331

0.95

0.11

1.0

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

149

960

0.97

0.10

3.2

3.4

mg/l

7.9

8.3

0.29

117

765

(3015350) Toxocara sp Ab [Presence] in Serum

1.16

0.10

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.13

0.10

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

224

1375

1.02

0.10

1.8

2.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

641

0.97

0.10

1.6

1.7

ug/l

9.4

8.7

0.72

641

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

241

1481

1.02

0.09

1.3

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

143

0.92

0.09

1.1

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

418

0.96

0.09

1.3

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

231

1.06

0.09

3.1

3.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

354

0.96

0.09

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

127

1.09

0.09

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

373

0.96

0.09

1.6

1.5

—

(3024471) HLA-A [Type]

103

665

0.97

0.09

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.07

0.09

1.0

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.10

0.08

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

177

1087

1.02

0.08

1.3

—

(3007700) Barley IgE Ab [Units/volume] in Serum

134

1.08

0.08

1.0

u/ml

0.5

11.7

0.50

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

320

0.96

0.07

1.0

1.1

u/ml

0.4

1.8

0.65

171

(3003721) Smooth muscle Ab [Units/volume] in Serum

202

1.05

0.07

1.1

u/ml

3.2

1.8

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.08

0.07

1.1

nmol/24h

154.8

89.4

—

(40758292) HTLV I+II Ab panel - Serum

326

0.96

0.07

1.3

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.06

0.07

4.2

5.4

mmol/l

0.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

320

1980

1.01

0.07

1.6

1.7

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

141

1.07

0.07

1.1

u/l

9.0

10.7

0.29

141

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.85

0.07

1.3

—

(3025130) Human papilloma virus identified in Specimen

775

4888

0.99

0.05

1.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

381

0.97

0.05

1.6

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

139

886

0.98

0.05

2.8

au/ml

116.6

153.5

0.37

129

(40763480) Human metapneumovirus Ag [Presence] in Specimen

101

0.93

0.05

1.0

1.3

—

(44806420)

411

0.98

0.04

2.3

2.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

305

1.03

0.04

8.5

7.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3797

23836

1.00

0.03

2.0

1.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

298

1853

1.01

0.03

1.0

1.1

u/ml

1.7

2.9

0.47

576

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.93

0.03

1.1

1.0

u/ml

0.1

0.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

124

787

0.99

0.03

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

225

1.03

0.03

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

163

0.96

0.03

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

107

1.05

0.03

5.0

4.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.92

0.03

1.4

1.3

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

194

1.03

0.03

1.0

u/ml

0.2

1.6

1.22

147

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

244

1518

1.01

0.03

1.4

1.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

114

1.04

0.02

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

124

0.96

0.02

9.5

5.3

—

(3024932) HLA-DR beta [Type]

102

645

0.99

0.01

1.2

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

0.94

0.01

1.0

1.4

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.06

0.01

7.8

6.6

—

(3001729) Color of Synovial fluid

146

1.03

0.01

1.9

1.7

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

110

1.03

0.00

5.1

4.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.98

0.00

1.5

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.96

0.00

38.7

10.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.00

0.00

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

1.02

0.00

8.6

10.3

e6/l

94.1

354.0

—

(3051101) Glucose [Moles/volume] in Cord blood

283

1.00

0.00

4.6

5.6

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

275

1.00

0.00

1.7

mg/l

1.5

1.7

0.46

233

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

107

1.00

0.00

1.0

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

229

0.99

0.00

1.6

1.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

160

0.98

0.00

1.0

1.1

u/ml

0.7

13.1

0.49

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.97

0.00

1.1

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.87

0.00

2.3

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.95

0.00

1.1

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.02

0.00

1.0

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.85

0.00

1.0

1.1

—

(3034614) HLA Ag [Interpretation]

1.01

0.00

1.0

1.2

—

(3006407) Chromogranin A [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

68.5

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.01

0.00

1.0

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

7.6

—

(3039542) Porphyrins [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.00

0.00

1.0

1.2

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.94

0.00

1.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

0.93

0.00

1.3

1.2

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.96

0.00

1.3

1.5

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: E4_PCOS_CONSORTIUM_EXCLUSIONS – Exclusions for E4_PCOS_CONSORTIUM

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Exclusions for E4_PCOS_CONSORTIUM

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Exclusions for E4_PCOS_CONSORTIUM (E4_PCOS_CONSORTIUM_EXCLUSIONS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints